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PREFACE 
Malar~a mfection and disease have exacted a heavy burden on sub-saharan Africa, where the great 
majority of the world s malaria occurs In t h ~ s  region, the health and economic burden of malana sur- 
passes that of all other diseases In these endem~c areas, children are at greatest r~sk and approximately 
1 5 million ch~ldren d ~ e  ach year of malaria Exacerbatmg this problem for many years were mad- 
equately funded, staffed, or organ~zed malar~a control programs throughout the region In Malawi, the 
situation 1s no d~fferent Malarla has been respons~ble for high levels of morbidity and mortality and has 
only recently benefitted from improved staff~ng and resources 
In 1981, the United States Agency for Internahonal Development (USAID) established the Africa 
Child Surv~val Initiat~ve - Combattmg Childhood Commun~cable Dlseases (ACSI-CCCD) Project, form- 
ing partnerships with the government of Malaw and 1 2  other sub-Saharan Afr~can countries to assist 
them m improving their capaclty to reduce childhood dlness and death caused by vacclne preventable 
illnesses, diarrheal diseases, and malana In ma law^, ACSI-CCCD efforts1 and work supported by USAID/ 
Malaw~ under the Promoting Health In Chlld Surv~val Project2 emphasized the need for wr~tten pol~c~es 
and realistic plans for malana control programs and assisted in developing health information systems 
and in conducting operational research to support these programmat~c imperat~ves Begun in 1992 as 
a 4-year project, the Health and Human Resources Analysis for Africa (HHRAA) Project was developed 
to cont~nue fforts toward progress achieved through CCCD efforts Its chief goals are to identlfy and flll 
informahon gaps to improve dec~s~ons, polic~es, and prachces 
T h ~ s  document was written as part of the HHRAA Project to document Malawi s poky  develop- 
ment process dur~ng the period 1984-1993 The focus of Malawi s activlhes was to define a locally 
appropriate malaria control policy and an effective malana control program on the bas~s of knowledge 
obtained from evaluat~on of existing disease control activlhes and from relevant operahonal research 
The document is mtended as a case study descrlb~ng the Important link between gathenng informahon, 
developing a talented group of nat~onals, and supportmg appropnate decision malng The document 1s 
also ~ntended as a tool for mtercountry workshops and/or actimhes focusmg on malar~a pollcy Malawl s 
progress In developing a malar~a control pollcy and program could have Important ram~flcatlons for 
other national disease control program efforts In Afnca and for a broader regional formulation of ma- 
laria control policy 
Further malaria poky  development In Malaw and in the region wdl requre the commltrnent and 
efforts of many Ministry of Health officials, nahonal pollcy makers, and malaria program managers in 
sub-saharan Africa donor organizahon personnel ~nvolved In program and policy development, and 
parhcipants In intercounty actrvlties of the USAID-World Health Organizatlon/Africa Regional Off~ce 
project With the~r concerted efforts, lessons learned through Malawi s process of policy and program 
development as described In t h ~ s  document may help strengthen malarla control programs throughout 
Afnca 
ACSI CCCD efforts In Malaw~ were begun In 1984 scheduled to end m 1988 and conhued unbi 1990 to complete the 
Mangochl Malar~a Research Project 
2Th~s project began In 1988 and cont~nues through the bme of publ~cat~on 1995 
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EXECUTIVE SUMMARY 
In Malawi, malana infecbon and disease represent formidable problems Malaria is the leading 
cause of illness and one of the major causes of death among children under the age of 5 years During 
the decade from 1984 to 1993, the Government of Malawi (GOM), in collaboration with international 
agencies, systematically addressed its options for controlling malana Dunng these years, Malaw de- 
fined a locally appropriate malaria control policy and began to develop an effecbve control program 
This document descnbes the successes and limitations of efforts that resulted in what is generally consid- 
ered important progress in malaria control policy and program development Malaw's activities are 
presented as an example, a case study, of a country s efforts towards institubonalizmng malaria control 
capacity at the national and local levels This document details the process that Malaw employed - a 
process that used technical issues to engage key participants, a process that developed a national policy, 
two 5-year operational plans, treatment and prevenbon guidelines, and an infrastructure, and a process 
that developed the skills of people who became the resource base for sustained malaria control 
Malawi's malaria policy and program development process is presented in chronologic sequence 
1) the status of malaria and its control in Malawi in the early 1980s, 2) the period from 1984 to 1989, 
covering the initial development of a national malaria control policy and the first 5-year plan, and 3) the 
penod from 1989 to 1993, covering the evaluation of the first 5 years and the development of a second 
5-year plan The process questioned "what is known" and "what needs to be known" to develop appro- 
priate policies, plans, and programs Consequently, the document provides examples of operational 
research used to establish a local information and knowledge base, which in turn led to policy and 
program development The informabon and knowledge base is further descnbed in terms of under- 
standing the problems of malaria, the intervenbons necessary for its control, and the exlsting patient and 
health worker practices 
The success of Malawi s process can be measured in many ways in the rational nature of the policy 
developed (a policy that established a national malana control program responsible for guidance, w~th 
the implementation of malaria treatment and prevention integrated into general community, clinic, and 
hospital care), in landmarks reached (e g , a Ministry of Health [MOHI-approved National Malaria 
Control Plan, health education materials developed, pnnted and distributed), and in its engagement of 
a broad base of people in health-related fields (policy makers, public health professionals, clinicians, 
traditional health workers, laborator~ans, health educators, pharmacists) On the other hand, a decade is 
a relatively short time, and a malaria control program demands a long-term investment Thus, while 
progress has been made, some areas require further attention and represent challenges to be addressed 
Malaria program milestones and challenges are summarized below 
MILESTONES 
Establishment of the Nat~onal Malana Control Program In 1984, a Nabonal Malaria Control 
Committee was established to provide guidance and oversight to a National Malaria Control Program 
A committee chairperson and committee members were selected from various parts of the health sec- 
tor The national program was established, and a program manager was identified and installed within 
the Department of Preventive Servlces 
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Elaboratron of the Natronal Malana Control Polrcy and Plan Durlng the decade, a National 
Malarla Control Policy was drafted, revised, and approved by the MOH Two 5-year plans (1985-1989 
1990-1994) were developed, approved, pmted, and dlstrlbuted w~th the mvolvement of chnmans, 
nurses, laboratorians, pharmac~sts, health educators, and other health professionals 
Development of Malana Treatment and Prevention Guidelrnes Starting in 1984, malarla 
treatment and prevenhon gu~dellnes were discussed, wr~tten, approved, printed and d~stributed to all 
health fac~lities and clin~clans (med~cal asnstants, clinical officers, nurses, and phyaclans) in the county 
The gu~delines were developed after revlewlng data collected from a varlety of sources, including stud~es 
of drug efficacy, health worker behavlor, and patlent access to and utlhzahon of health services In 
response to new information and evolvlng patterns of drug eff~cacy, these guldellnes were formally 
revlsed and reprmted on several occasions dunng the decade 
Preparation of health education matenals From 1986 to 1988 and agam in 1992 and 1993, 
health education mater~als for malaria control and prevent~on were d~scussed, developed, produced, and 
d~stributed to health faclllt~es and to medla throughout the country The development of these materials 
was alded by mformatlon collected from local and nabonal surveys 
Formulatron of malana control pol~cy based on locally acquired information The develop- 
ment of national malarla control policies, natlonal treatment and prevent~on gu~delmes, and mater~als 
for health education and other program components was based on information acqu~red wlthin the 
country through operational research actlvltles lnvolv~ng teams of Malawian researchers 
Conduct of polrcy and coordination meetings Nahonal and reg~onal meet~ngs were held to 
dlssemmate study results and to make poky  and program declslons based on study fmdings 
Development of a natronal program rnfrastructure The Nat~onal Program cons& of a central 
off~ce with two to three staff members The program provldes a technical base and program guidance, 
but the actual dellvery of prevent~on measures and patlent care servlces remalns the respons~bllity of 
Dlvision of Clinical Semces, MOH Consequently, the structure of the malana program is horizontal, 
wth dlsease control fully integrated and programmed m the chn~cs, health centers, and hospitals throughout 
the country 
Information gathering was accompl~shed through a lmk with the health informahon system for data 
revlew and trend assessment, sentinel sltes were ident~fied to examlne speclfic questions The program 
developed local research capaclty through a network of trained staff m hosp~tals and cllnlcs across the 
country It also established mechanisms to monltor and re-examine parameters related to malana dis- 
ease prevention and control When the nahonal program undertook an internal and external evaluat~on 
of the program m 1989, the assessment benefited from the ava~labihty of data from ~ t s  monltorlng 
mechanisms 
Contnbutron to the regronal and international malana control experience The Nat~onal 
Malarla Control Program has contributed directly to reglonal and lnternat~onal knowledge of malarla 
and its control through disseminahon of research results and decls~ons made based on the results 
Malawis experience has had an Impact on the malar~a control policy of the World Health Organlzahon 
(WHO) and disease control policles of ~ t s  ne~ghbors Research projects conducted m Malawi have estab 
lished operahonal standards In the field of malarla control (e g , evaluabon of In vlvo drug efficacy, 
cl~n~cal criteria for exam~nlng severely 111 pat~ents) 
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Involvement of partners m a multrsectoral attack on malana The malaria control program has 
made important strides in health worker training and supemsion, in consistent dialogue wlth the health 
education unit, and in full coordmation wth Clinical, Maternal and Child Health, and Primary Health 
Care Semces in the MOH Future efforts wll rely on the strengthening of the coordination among these 
groups The opportunity to engage prrvate and estate clinics and practitioners, traditional healers, vol- 
untary agencies, and other groups working in the health sector has not yet been fully exploited, the 
participation of these individuals and groups wdl come only with the availability of staff and resources 
Development of personnel to conduct malana control The leaders of initial efforts in the 
malana control program made a conscious effort to include people from a number of disciplines and to 
nurture their development These efforts have persisted and continue to prowde opportunities for young 
health workers to learn and participate as actwe members, not simply observers This effort, as much or 
more than any other, wll ensure the development of future leaders in malaria control in Malawi 
CHALLENGES 
The control of malaria in Malawi is a dynamic, ongolng process The investments to date in idenb- 
fying the challenges and effectwe interventions and in establishing a competent national staff have been 
essential initial steps Continued investments in these areas will be required as the national attention 
moves to wider application of the control strategies, increased coverage, and greater access of the 
Malawian population to malaria control services Distinct challenges remain that will require conlnued 
support and innovation to ensure that Malawi s malaria control program is effective 
Ensunng adequate resources for malana control As with almost all disease control programs in 
developing countries, the malana control program in Malaw has been faced with a limited MOH budget 
and conttnued requirements for donor assistance While budget l~mitations have not jeopardized the 
control program to date, they have limited the planning capability and limited accomplishments by the 
national program Recently available data from the economic evaluation of the cost of malana to the 
country and its people provide important documentation of need, the MOH and donors must weigh this 
need against other needs wthin the health sector 
Contrnued attention to develop the malana control rnfrastructure The small staff (both tech- 
nical and administrative) and inadequate central resources (e g , vehicles, basic equipment and supplies) 
for the Nalonal Malaria Control Program also limit the capabilities of the program to prowde regional 
and district level guidance, supemsion, training, and other services 
Development of program management and administratwe capac~ty As is largely the case 
throughout the MOH, the staff of the malana control program have l~ttle or no tra~ning or expenence In 
management and supemsion This situa'non is unlikely to change except as lrnprovements occur more 
wdely wthm the MOH Addibonal efforts to train potenhal leaders in these slulls wll need to be considered 
Ensunng sustarnabllity In malana control programming The National Malaria Control Pro- 
gram faces the continual questton of adequate staff and resources to carry out its mission, as do other 
disease control programs Recent efforts to train junior staff will undoubtedly foster the sustainability of 
the program, and conlnued informed advocacy by senior public health officials will remain essential to 
developing an effective malaria control program 
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MAJOR COMPONENTS OF MALAWI'S SUCCESS 
Several elements of malar~a control program development in Malawi should be highlighted While 
these may not be models for other countries, they represent lessons for others to cons~der as they 
examine their own d~sease control poky  development process 
The study of technical Issues served as an entry pornt for engagement and contmued 
rnvolvement of key partrapants This document descnbes the process of conducting operational 
research, examlnlng study results, and maklng decisions based on locally collected information While 
this process has been central to pohcy, planning, and program development, it has also engaged junior 
MOH staff (clinicians, nurses, public health staff, and other decision makers) and university staff and 
students By obtaining skills needed to gather data and to apply results to policy and program issues, 
staff and students have strengthened their ability to contribute to the malaria control program 
The operational research act~vities engaged a variety of health care profesaonals, including physl- 
clans, who retam much of the decision-maklng power within the health sector Physicians involved in 
these activities were encouraged to seek the relevance of their research to the malaria control program 
Cllnlcians participated d~rectly in evaluating determinants of antimalarial drug eff~cacy, In drug efficacy 
mon~tor~ng, and In examining diagnostic crltena for malar~a nd other d~seases w~th overlapping symp- 
toms (acute respiratory Infection) From this engagement, cl~n~cians further recogn~zed the role and 
determinants of patlent partxipation in effective malarla control Subsequently clinicians rewewed the 
knowledge, attitudes, and pract~ces data along wth health educahon and publlc health specialists to help 
focus malar~a control programming efforts Clinicians also recognized the need to evaluate the eco- 
nomlc Impact of malaria and disease control efforts In the context of people s economlc hm~tabons as 
an important step toward allocating resources and creating a program relevant to patlent needs and 
means 
Technical lssues that are h~ghlighted In the document include 
Results of drug efficacy studies leading to changes in malaria treatment guldelmes, 
Results of studies in malaria in pregnancy leading to changes In prevent~on gudehnes, 
Knowledge, attitudes, and practices (KAP) survey results leadlng to health education 
mater~al des~gn, 
Results for an economlc study focusing donor and MOH attention to malaria issues, 
and 
Studies of severe and compl~cated malaria provld~ng information for improved treat- 
ment guidelines 
Focused operatronal research supported malana program development The contribution of 
operational research to program development has not always been adequately understood or supported 
However, the experience in Malawl demonstrates the value of a partnership between program-relevant 
research and program development, in wh~ch focused scientific t h ~ n l n g  supported and promoted pro- 
gram development 
In the evolut~on of the initlal ant~malarial drug efficacy studles and the subsequent studles to monitor 
drug efficacy, mveshgators in Malaw were faced unth the quesbon how wl we know when the ant~malanal 
drug is no longer effective? This question was answered by defining the parameters of effectweness 
(1 e , to resolve malar~a-associated dlness for a sufficient length of time to permit full recovery of the child 
~ncludlng hematologic recovery) and then by developing a scient~fic study to examine whether the drug 
accomplished these requirements Through thls process, the information collected became directly rel- 
evant to the program s decision of when to change the first-line antimalarial drug 
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Another example of the partnership of research and program development is the Mangochi Malaria 
Research Project (MMRP), conducted in Mangochi District This project was developed to address a 
specific set of questions regarding whether or not a highly effechve antimalarial drug used for prevention 
of malaria in pregnancy would lead to a reduction in the frequency of low birth weight in the population 
This population-based research program led to an answer to this question of regional importance, and 
at the same time, results of the study led the Ministry of Health to seek an effective, affordable, and safe 
reglmen that could be promoted for malaria prevention in pregnancy In addition, important observa- 
tions on malana in pregnant women and their infants were made The research fostered an ongoing 
collaboration between Malawian and U S -based malaria experts that continued to support systematic 
approaches to poky and program development 
While operational research served many important purposes in Malawi, the operational research 
described in Malaw is not meant to be a recipe for all such studies to be conducted in each malaria- 
endemic county in sub-Saharan Africa In fact, it is hoped that information disseminahon will play an 
increasing role so that relevant information from one county might be examined critically and adopted 
as appropriate to the local circumstances in another county in the same region For example, a large- 
scale longitudinal study of malaria prevenhon in pregnancy, like the MMRP, need not be repeated in 
each county Efforts are currently under way to develop simpler rapid assessment tools that can provide 
relevant information wthin a county These tools should facilitate the adoption of the broad principles 
of malaria prevention in pregnancy and help tailor the program to local needs 
The development of the malana control infrastructure and management capaclty IS best 
addressed by training Although much remains to be done within Malawi in infrastructure and 
management development, the MOH has made a substantla1 effort to include staff in a variety of catego- 
ries and levels, promde training, and offer young staff leadership opportunities Malawi s malaria pro- 
gram has been built on the recognition that increasing management capacity requires both short- and 
long-term investment in training 
The ulbmate sustainability of the malaria program, or any other disease control program, wll be its 
ability to entlce people to participate, to support them, to show progress, and to reward them for work 
well done Malawi's program has contributed on these fronts, largely through the recognition by a few 
that these issues were important for the sustained nature of the effort Clinical officers were brought Into 
the decision mahng role, laboratorians were involved on a co-equal basis, and additional staff were 
trained in malaria control issues on their return from study abroad 
IMPLICATIONS FOR PROGRAM AND POLICY DEVELOPMENT ACTIVITIES IN 
SUB-SAHARAN AFRICAN COUNTRIES 
Malawi s experience accrued in the decade before the leadership of WHO and member countries 
adopted the Global Strategy for Malana Control in Amsterdam in October 1992 (WHO 1993) The 
Global Strategy defines several control strategies, placing priority on the development of effectwe ma- 
lana case management and prevenbon services for all populations at nsk for malaria infection and 
illness, both acute uncomplicated and severe For effecbve case management, the Global Strategy rec- 
ognlzes that a national program must have a database to understand the current efficacy of antimalarials 
Because of changing levels of antimalarial resistance, the strategy emphasizes that guidelines for case 
management cannot be rigid The Global Strategy's focus on prevention highlights the ~mportance of 
malaria prevention in pregnant women and the "personal protection" potentially provided by insecti- 
cide-impregnated bednets The Global Strategy also emphasizes that a malaria control program capable 
Xlll 
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of provldlng effective treatment and preventive sennces will need a monitormg and evaluatlon mecha 
nlsm, the results of whlch may prompt revlslon of malaria control plans and strategles Flnally, the global 
strategy acknowledges that for many countrtes limttations of resources and infrastructure will mean that 
locally relevant and affordable priorities will need to be established for malaria control 
The Internal and internat~onal collaboration embraced by Malawl as it forged its National Malarla 
Control Program influenced the development of the Global Strategy and showed Malaw] s posltion in 
the context of country-level programs As noted in Box 9, the informat~on generated from studles In 
Malawi that evaluated therapy efflcacy and prevention effectiveness and set standards for assessing 
household practices and household and national expenditures has relevance, both within the reglon and 
globally 
Malawl's experience with malarla control comes at a tlme when the Global Strategy must define its 
relevance to local conditions The translation of the Global Strategy to natlonal and local programs is 
not dictated by formulas, but rather evolves from an assessment of malaria control prlorltles and of both 
fmancial and personnel resources available to the program The Iterative process of monitoring and 
evaluation (~ncludlng operational research) that supports an offlcial plannlng process embracing prompt 
and appropriate revisions in malarla control strategies is the core of program operations This cyclical 
process forms the basis for effectwe and efficient malarla control, permittmg adaptation to changing 
epidemiology and economlc reallties 
MALAWI'S NEXT STEPS 
The challenges now facing Malawi s malarla control program are clear Although the national ma 
larla treatment guidelines have been dissemmated nationally, efforts need to be focused on program 
support strategles that emphasize trainmg, supennsion, monitoring and evaluatlon through the health 
information system, administrative coordination, and operational research The rate of expansion of 
program coverage will be dictated by resources and by the need to have a more systematic monitoring 
and evaluation component in the early phases to ensure that program process and impact are optimal 
The relationship between the Global Strategy and natlonal malaria control programs must be dy- 
namic Local translation and adaptation of the guldance of the global strategy requires nahonal mtiatlve 
and perspective In thls context, the experience In Malawi has particular value The national commit 
ment to developing malarla control capacity w~ll foster the opportunity to evolve concurrently wlth the 
renewed global commitment to strengthen malarla control 
Introduction 
Malawi, a densely populated country in sub-Saharan Africa, has numerous health challenges to 
address, including its high rate of infant and child mortality (Box 1) From 1984 to 1993, in collabora- 
tlon with international agencies, the Government of Malawi (GOM) systematically addressed the adverse 
effects of malaria, the leading cause of illness and one of the major causes of death among children 
under the age of 5 years (Box 2, Figure 1) The focus of these activltles was to define a locally appropri- 
ate malarla control policy and an effective malaria control program on the basis of knowledge obtained 
from evaluation of existing disease control activltles and from focused operational research efforts 
Strong government commitment to developing the required programmatic infrastructure and the neces 
sary database for rational policy development was critical to the Malawi program Malawi is a successful 
example of a productive partnership of research, policy development, and program implementation 
Malawi's progress in developing a malaria control policy and program has ramifications for other na- 
lonal program development efforts in Africa and for a broader regional formulation of malaria control 
policy 
Box 1 Malaw~ 
Populatlon (1 992) 10 4 mllllon 
I MALAWI 
Populatlon annual 
growth rate (1980 92) 4 3% 
Populatlon denslty (1 992) 88 per sq km 
Llfe expectancy (1 992) 44 years 
Crude birth rate (1992) 55 per 1000 populatlon 
Crude death rate (1 992) 21 per 1000 populatlon 
GNP per caplta (1 991) $230 
Under-5 mortallty rate (1992) 226 per 1 000 llve blrths 
Infant mortallty rate (1 992) 143 per 1,000 hve births 




Parasites PIasmodrum faic~parum [respons~ble for 80%-90% of malaria infections) 
P malar~ae (responskble for 10%-20% of malaria ~nfectlons), P ovafe (rare) 
Vectors Anopheles gambrae, An funestus 
Endem~crty Meso- to hyper endemic except tn rsolated higher altitude rnounta~nous reglons 
Transm~ssron Perennral at lakeshore and lower Sh~re Rlver valley, more seasonal on the plateau 
Entomobglc 
Inoculation Rate Variable depending on regton, estmates range between f 5 50 ~nfective bttes per 
person per year 
The health lmpad of malama in Malam 
F~gure 1 Hospital adm~ssions due to 
malaria, Malawi, 1982-1 990 
Total adm~ss~ons (thousands) 
Year 
Figure 3 Most common causes of 
hosp~tal~zation among children less 
than 5 years, Malawi, 1990 
F~gure 2 Ten most common diagnoses 
made during outpatient v~sits, ma law^, 1990 
Helrn~nths 30 7 
BoneNo~nt 33 7 
exually Transmitted 
eases 33 9 
a 46 1 
Figure 4 Causes of hosp~tal deaths among 
children less than 5 years, Malawi, 1990 
Measles 10 7% 
Source Malaw1 Mlnlstry of Health Health lnforrnat~on System 1991 
This document describes Malawi's development of a malarla control program, focusing on the 
program elements and infrastructure that evolved Using basic epdemiologic methods, the Ministry of 
Health (MOH) defined the problem of malana, effective mterventlons, and current malaria prevention 
and treatment practices (Figure 5) With thls information, the MOH formulated malarla control policy 
and refocused its national malarla control program 
F~gure 5 Information sources for policy development 
lnformat~on b Pollcy development 
Sources Minlstry of Health 
Mrnistry of Health Health Informatron System 1 
Mrnrstry of Health Office of Health Statrstrcs Drvlslon of Prevention Services 
ACSl CCCD (USAID support) 
Mangochl Malaria Research Project 
Malarra Research Project 
(Queen Elizabeth Central Hosprtal) 
Communrty Health Scrences Unlt 
(Drsease Control Programs) 
Natlonal Malarra Control Program 
Natlonal Malarra Control Commlttee 
Program Manager 
Status of Malar~a Control Programs in the Reg~on 
and in Malaw1 In the Early 1980s 
In the early 1980s, much of Africa faced an increasingly serious public health crisis caused by 
malaria, yet it had little support, guidance, or experience in controlling malaria The international effort 
to eradicate malaria in the 1950s and 1960s had faded to include most of Africa south of the Sahara 
(with the exception of Ethiopia, South Africa, and Zimbabwe) because the vector control interventions 
of the eradication program were not considered feasible in most of Africa The intensity of malaria 
transmission and the limited health infrastructure available to support a program constituted impedi- 
ments to the inclusion of most of this region As of 1984, a limited number of African nations (Nigeria, 
Ethiopia, Zimbabwe, Swaziland, and South Africa) had approved written malaria policies and organized 
funchoning malaria control programs 
Although health stahshcs in the vast majority of African nations indicated that malaria was one of 
the major causes of childhood mortality, few international organizations were committed to controlling 
malaria infection and disease, and consequently, few nations were prepared to embark on malaria 
control efforts Looming on the horizon was the specter of decreasing effectiveness of chloroquine 
(CQ), the most widely used and available antimalarial drug in the region Parasite resistance to this drug 
was first detected in East Africa in 1978 and was spreading into Central and West Africa Drug resis- 
tance confirmed the prevailing attitude that malaria was not controllable in Africa the erosion in the 
efficacy of presumably the only method of malaria control, mass distribution of CQ, caused many policy 
makers and national public health authorihes to believe that malaria prevenhon efforts would have to 
wait, despite malaria s magnitude as a public health problem 
l A Standard malar~a treatment In Malaw1 In 1984 
In 1984, Malawi, like many of its neighboring countries, had no organized malaria control pro- 
gram The standard malaria treatment in its unwritten "policy" relied on chemoprophylactic and treat- 
ment doses of CQ for children under 5 years of age and pregnant women Older children and other 
adults were not targeted for prophylaxis but received treatment with CQ when they presented wth a 
febnle illness However, the effectiveness of these regimens remained untested Although the World 
Health Organization (WHO) had performed testing in 1978 and 1980 for resistance of the malaria 
parasite to CQ in Malawi, no surveillance system had been established to determine the presence or 
levels of CQ resistance on an ongoing basis, even after resistance had been detected in the neighboring 
countries of Kenya and Tanzania in 1978 
I B The Afrrca Chrld Survrval Inrtratrve-Combattrng Ch~ldhood Communr- 
cable D~seases (ACSI-CCCD) and the Promotmg Health In Chrld Survwal 
Projects 
In 1981, the United States Agency for International Development (USAID) established the ACSI- 
CCCD Project, forming partnerships with the government of Malawi and 12 other sub-Saharan African 
Status of malaria control programs 
countries to assist them in lmprovlng their capacity to reduce childhood illness and death caused by 
vaccine-preventable illnesses diarrheal diseases, and malana ACSI-CCCD efforts (1984-1988 with 
continuation for the Mangochl Malana Research Project until 1990) and work supported by USAID 
under the Promoting Health in Child Sunnval Project (1988-1993) emphasized the need for wntten 
policles and reallstlc plans for malarla control programs These projects assisted in developing health 
information systems (HIS) and in conductmg operational research to support national programs 
Establishing the Organizational Structure and 
Developmg the Policy for Malaria Control: 
1984- 1989 
"Part I1 Establishing the organizational structure and developing the policy for malaria control 
1984-1989 describes the s~gnificant malaria-related program and policy activities and the effect of 
Malawi s operahonal research agenda on malana policy during this period The studies that contributed 
to policy development and change are organized by the following categories the problem of malaria, 
malaria interventions, and malaria treatment and prevention pracbces 
II A Summary of malarla program and policy accompl~shments 
During the years 1984 to 1989, Malawi established the basic elements of its malaria program a 
malaria control committee, a committee coordinator, a national manager for the malaria control pro- 
gram, a policy (outlined in a 5-year plan and treatment guidelines), and health education materials 
(Figure 6) Policy and program activities were informed by research undertaken to assess the current 
malaria situation - dlsease prevalence, caretakers' knowledge, attitudes, and practices (KAP), treat- 
ment in the community and in the health facilities - and to evaluate treatment measures, including 
antimalarial drug efficacy (Figure 7) 
F~gure 6 Malar~a program and pollcy m~lestones 1984-1989 
1984 1985 1986 1 987 1988 1989 
Formed Malar~a Control Comm~ttee 
Named malarla coord~nator 
Developed malarla control pollcy 
Completed 1985 1989 Malar~a Control Plan 
Wrote Gude for Management of Malaria 
Developed health education mater~als 
Appomted nat~onal malar~a control manager 
Held nat~onal meetmg 
Held symposium on 




f~rst years of 
malarla control 
program 
3A number of stud~es conducted dunng the years 1984 through 1993 contr~buted to the body of knowledge regard~ng malana 
treatment and prevention but d ~ d  not directly affect Malaw1 s pol~cy These stud~es are not descr~bed In th~s document 
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F~gure 7 Stud~es affectmg malar~a pollcy development 1984-1989 * 
1984 1985 1986 1987 1988 1989 
Malaria prevalence in facllitles & community 
Evaluation of antimalarial resrstance 
Cllnical response to antimalarials 
Community practices related to malaria control 
Perinatal malaria prevention 
Outpatient & inpatient treatment practices 
Reevaluat~on of antimalar~al drug resistance 
Treatment of severe malaria 
Malarla and infant mortality 
Mangochl Malar~a Research Project 
"Time l~ne lnd~cates the year rn whlch the stud~es were begun 
II B Estabhshmg the organ~zat~onal structure 
In 1984, Malaw s National Malaria Control Committee was formed, and a chalrman of the com- 
mittee was named Following the policy of the MOH in Malawl, malana control actlvltles were ~mple- 
mented at the three levels of health care delivery and were Integrated withln exlstlng programs At the 
national level, the malarla control committee developed plans for monltonng, evaluation, and research 
activities The committee made policy recommendations that were then submitted to the MOH, GOM 
for approval The positlon of program manager was established at the national level within the Depart- 
ment of Preventwe Servlces (Flgure 8), and the appointed manager worked with regional and distrlct 
health offlcers to ensure that training, health education, and laboratory and pharmaceutical supphes 
were sufficient for program implementation The logistics of drug supply remamed in the hands of 
Central Medical Stores and distnct health officers 
The regional and district health officers supennsed acht ies  at thelr respectwe levels Each year, 
regional and distnct plans were flnallzed at annual regional revlew meetlngs Health servlce dellvery and 
primary health care (PHC) workers were tralned and supervised at both reglonal and dlstrlct levels 
Personnel from the natlonal level parbcipated in some of the tralning and supervisory acht les  when 
necessary A manual for training health servlce dellvery workers was developed and distributed to all 
dlstrlcts In 1985 Slnce that time, the majonty of health semce delivery workers and other cadres In the 
community have received refresher training In malaria therapy The training program Involved commit 
tees and other groups that provided support for health educabon at the community level (e g , distnct 
development committees, village health commlttees, area primary health care commlttees, community 
leaders) Tradltlonal birth attendants (TBAs) and vlllage volunteers were tralned and supplied wlth drugs 
and training alds to provide malaria chemoprophylaxls and treatment at the community level 
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Flgure 8 Organ~zatlonal structure of the Malawl Mlnlstry of Health 
I M~n~ster of Health 
Pr~ncrpal secretary for Health 
Ch~ef of Health Serv~ces 
Other ~ervrces 
(Clln~cal Nurs~ng etc ) 
D~sease Control Programs 
Malar~a control Program Other ~ l se i se  Control 
(Tuberculos~s Acute resp~ratory ~nfect~on Leprosy etc ) 
A number of publrc and prrvate organrzatrons and ~ndividuals provrde health semces in Malawi gov- 
ernment mlssrons and other nonprof~t organlzatrons, rndustry, prtvate physrcians, tradit~onal healers and 
tradlttonal b ~ I h  attendants 
The Mtnistry of Health (MOH) sets health polrcy, prowdes direct health care, coordtnates other health- 
related resources m the country and develops strategtes and programs for disease control, drsease preven- 
t~on, patrent care, and health care quality The government prowded nearly half of all health serutces, prtma- 
fily curatwe serums, until 1973 when a prevention-orrented Maternaf and Chdd Health program was 
establshed with antenatal and under-5 cltntcs throughout the country The MOH has begun to decentralrze, 
gtvrng more responstkut~ty for plannrng and management to the three regions and 24 distrrcts The plan for 
basic health servrces calls for development of prrmary health care acttvrties tn prtmary health centers, 
subcenters, and health posts, as well as at the commun~ty level by setected communtty members Health 
centers are consrdered essenttal to management and supewislon of vtllage4evel prrmary health care actrvities 
After the government, the mission-sponsored health system, the Prlvate Hospital Assoctation of Malaw1 
(PHAMf Eater called the Ghrrstlan Hospital Association of Malawr is the largest provtder of curatwe factllt~es 
and prevention programs The Malaw1 government prov~des PHAM wrth approx~matefy 40% of tts revenues 
PHAM operates 20 otthe natton s 49 hosprtals, lt also operates a number of subsrdraryfac~l~t~es that prov~de 
oufpaf~entservrces 22 prtmary heafth centers 100 health subcenters and feprosy center and tratnlng school 
A thlrd provrder of health care a Industry (e g large tea estates and urban manufacturmg ftrms) wh~ch 
provrdes outpatrent health servrces to employees and therr famthes 
In addit~on, the three prlnclpal urban areas of Lilongwe, Blantyre, and Zomba have a small number of 
prwate practrtloners In f 989 41 Malawian medical practlboners regrstered under the Medrcal Council of 
Malawr, ajong wlth expatriate physraans and clrntcaf officers staffed public and prrvate hospitals Over 5 000 
tradttionaf healers, located m both urban and rural areas provlde curative treatment. About 400 of these 
belong to the Herbalrsts' Assocration, whlch matntatns a hnk with the MOH 
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II C Developmg the malar~a control poky 
During the years 1984 to 1989, Malawi developed the pollcy documents needed for the newly 
organzed control program and promoted malarla control through information dissemination 
In 1985, a malarla control pol~cy was developed based on results of early fleld studles and was 
published in The Malana Control Plan 1985 1989 and the Gulde for Management of Malarm 
The Malaria Control Plan 1985-1989 outlined fwe basic malaria control strategies presumptive 
treatment of fevers in children and adults wth 2 5  mg basekg of CQ, continuous monitoring of 
antimalar~al efficacy, selective antimalarlal chemoprophylaxis (for pregnant women, immunosup 
pressed patients, children with recurring febrile convulsions or s~ckle cell disease), vector control 
(limited to major urban areas), and health education 
The Gulde for Management of Malarm was developed in 1985 and distributed to physicians 
cllnical officers, medical assistants, and senlor nursing staff (Flgure 9) The guide explained the 
results of In vlvo tesbng and recommended antimalarial drugs and their correct dosages The guide 
also recommended regular monitoring of in VIVO clinical response to CQ, amodiaqulne (AQ), 
sulfadoxine-pyrimethamine (SP), and qu~nlne The guide was updated in 1986, and two recom 
mendations contained in the 1985 guidelines were dropped from the 1986 guidelines Aspirin was 
no longer recommended as adjunct treatment for acute eplsodes In children because of concern 
over Reye s syndrome, and AQ was not recommended for chemoprophylactic use, although it was 
st111 considered an effectwe second-line antimalarlal treatment 
F~gure 9 Cover of Malawi's 1985 treatment gu~del~nes 
1 GUIDE FOR MANAGEMENT OF 
MALARIA 1 / 
/ FOR PHY!&IANS CLINICAL OFFICERS - 
MEDICAL-ASSISTANTS AND 
SENIOR NURSING STAFF An ofhc~at uorumment 0 t h  
U~LAWI H~NISTRY OF HEPLTH 
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Realizing the need to disseminate information to both caretakers and health facilities, the commit- 
tee developed health education materials In 1985, a dose-for-age chart was developed and widely 
distributed The chart (Figure 10) showed the correct number of CQ tablets to take based on a 
person's age, its use of pictures helped convey its meaning to the large numbers of people attend- 
ing clinics who could not read In 1989, Healthcom, a U S -based health organization, assisted the 
MOH in developing a wide variety of health education materials focusing on malaria treatment and 
prevention 
F~gure 10 Dose-for-age chart, Malaw1 
Yangonan~ pa ch~thunz~ lch~ ndondomeka 
ya kaperekedwe ka kolalokwln~ kuh 
mudz~we rn rnene mungom patwe 
monk hwala mwono 
In 1987, a national manager for malaria control was appointed, and the first national meeting to 
discuss malaria was held in Salima Officials from the MOH and from nongovernmental organiza- 
tions met and outlined a plan to implement malaria control efforts, with emphasis on strengthen- 
ing delivery at the community level The responsibilities and interrelationship of each level of the 
government in conducting the malaria control program were outlined 
In February and March, 1989, the Medical Association of Malawi hosted a symposium on malaria 
control in Afnca Participants included clinical officers and physicians from across the country, 
international, regional, and national experts, and government officials Malawi s guidelines were 
presented and discussed The symposium served two major purposes to widely disseminate infor- 
mation about study findings to clinical officers and physicians and to heighten the MOH s aware- 
ness of the problem of malaria and the new opportunihes for control efforts 
In June, 1989, a joint team of more than 20 officials from the MOH and nongovernmental orga- 
nizations in Malawi, United Nations Children s Fund (UNICEF), USAID, and WHO conducted a 
formal remew of the National Malaria Program Findings of this evaluation are discussed in Part III 
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II D lnformat~on gathered and ~ t s  effect on malar~a pollcy 
II D 1 Operat~onal research agenda 1984-1989 
The National Malaria Control Committee developed an annual plan for operational research actiw- 
ties To develop an effectlve malaria pollcy and program, the committee needed information In the 
following areas current information on the extent of the problem of malana, the efflcacy of malaria 
interventions, and optimal delivery methods and effectweness of malarla treatment and prevention 
practices 
The problem of malarla A WHO mission in 1973 had documented high mfection rates among 
children under 5 years of age, but Malawl needed current information on malana prevalence among 
those targeted for malaria control efforts Fever rates, P falcparum infecbon rates, and severe malarla 
dlsease rates m the communlty and in health facihties were needed to fully understand the extent of 
morbidity in potential target populahons and to understand the current burden of malana on the home 
and health fachties To compare the burden of malaria wlth that of other childhood diseases, informa- 
tlon was needed on overall, site-specific (home versus health facility), and cause-speclfic mortality 
Malarra rnterventrons Standard malana treatment and prevention in 1984 were based on WHO 
recommendations for malaria control in Africa treatment of acute malarla (febrde illness) wth CQ for all 
persons and chemoprophylaxis wth CQ for children under 5 years of age and pregnant women How 
ever, the efflcacy of these interventions was untested Although in vlvo and In wtro testlng m 1978 and 
1979 had shown that CQ was effectlve in a dose of 25 mg base&, clinicians from hospitals throughout 
the county during the 1982 and 1983 malaria seasons had begun to report an increase In break- 
throughs of clinical malaria among children enrolled in CQ (5 mg basekg weekly) chemoprophylaxls 
programs In addition, CQ treatment failures of slide-confirmed malaria were observed among children 
and adults At the same tlme, reports appeared in the international literature about expatnates l~ving or 
having hved in Malawi at some time during 1983 who had chloroqume-resistant malaria infections (Fogh 
et a1 1984, Overbosch et a1 1984) It was apparent that the efficacy of CQ in clearing parasitemla as 
well as malaria symptoms in children needed further exammation Because results from new studies 
began to show poor efficacy of CQ in therapeutic doses of 25  mg base&, ~t was unclear whether CQ 
could be beneficial when used In a program of low-dose chemoprophylaxis for pregnant women, and 
testing of lnterventlons was initiated for this group Questions remained about safe and effective ~nter- 
ventlons for severe malana, and studies were carrled out to clarify optlmal treatment for this manifesta- 
tion of malaria disease 
Malarm pract~ces With the knowledge that an effective malaria program requlres both community 
(caretaker) partlclpation and health facility dehvey, current knowledge of how caretakers and pregnant 
women treated malana and of how health workers provided malaria treatment needed to be evaluated 
so that appropnate actions could be taken to improve care in the communlty and, if needed, in health 
facihbes 
The next three sectlons review the results of studies conducted to evaluate the problem, the ~nter- 
ventions, and the pracbces A brlef descnpbon of the questlon or questions to be answered by the study 
and study findlngs IS followed by a summary of the effect of each study on Malawl s malaria pollcy 
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I I  D 2 Stud~es of the problem of m a l a r i a  
II D 2 a Prevalence of malar~a among ch~ldren In health dac~hties and In the commun~ty 
The questron 
To determine the extent of the problem of malaria in chddren, the number of cases of P falclparum In health 
facilities was assessed through routme outpatlent and inpatient reporting systems, the prevalence of malana in the 
community was established by community surveys 
Study findings 
The extent of malana In health facrlltles Data obtained from the routine outpatient and inpatient reportmg 
systems between 1980 and 19864 showed that malana, diagnosed on the basis of clinical signs and documented 
parasltemia was a problem of substanhal magnitude in health facilihes particularly among children under the age 
of 5 years (Figure 11) 
F~gure 11 Extent of cllnlcal malar~a nd paras~tem~a among ch~ldren less than 5 years of age, health 
facll~t~es, ma law^, 1980-1 984 
illness1 
OPD=Outpatient department Parasitema 
Among ch~ldren under the age of 5 adm~tted to hospitals cerebral malana signs accompanied malana In 17% of all 
malana admissions, and anemla accounted for progressively more admissions from 5% In 1980 to 14% In 1986 
Approximately 41% of children vlsiting health facllihes and clinics were parasitem~c (Flgure 11) Most (92%) of the 
infections among the children under 5 were of parasite density less than 2000 parasites/mm3 and asymptomatic 
Reports of malana from outpabent faclhhes were based on presumpt~ve d~agnos~s u ually fever w~thout slgns or symptoms associated w~th other 
d~seases Reports of mpabent malana were based on th~ck smear results though at bmes because not all hosp~tals had functlon~ng rnlcroscopes 
the mpabent dlagnosls was presumptwe Anemla m ch~ldren under 5 years who had no parmtes on a thlck smear was not reported as malana 
although anemla was often thought to be a d~rect result of rnalana ~nfecbon 
Deve lop~ng  the  malarla control  s t ructure  a n d  p o l ~ c y  1984-1989 
Fever and paraslte prevalence rn the communrty Children experienced a high number of febnle episodes regard 
less of season and location with an average of 1 3  ep~sodes per chlld per year In the dry season nabonwde and 1 7  
episodes per child per year at the lakeshore A great number of well children under 5 years were parasitemic At the 
lakeshore rates of parasitemla ranged from 64% in the dry season to 78% in the wet season Schoolchildren aged 
6 to 15 years had much lower rates of falciparurn infection only 29% were parasitemic and none were febnle 
Impact on polrcy 
These early prevalence surveys prov~ded support for the malaria policy s targeting children under the age of 5 years 
as an at risk group The magnitude of the problem provided justdicat~on for the intense focus on malar~a by the 
GOM urlthin the CCCD project The finding that anemia was increasing caused concern and promded additional 
evldence that CQ resistance might be increasing Thls potenhal increase in CQ resistance emphasized the need for 
ongoing evaluation of the efficacy of CQ and of ~ t s  effectiveness when used in a reglmen of prompt treatment wlth 
a full dose 
II D 2 b Pennatal rnalana 
The questzons 
Although chloroquine resistant P falclparum parasites were widespread In Malaw (Khoromana et al 1986) CQ 
remained the first-he drug because of ~ t s  ablhty to reduce parasite densities and cllnlcal illness As a consequence 
the exlstlng policy of CQ prophylax~s for all pregnant women was conhnued in antenatal clinics (ANCs) However 
the efficacy and effectiveness of CQ prophylaxis among pregnant women had not been examined and there was 
serlous concern that d CQ was not fully efficacious at therapeubc doses (25 mg basekg over 3 days) ~t mlght offer 
little beneflt when used as low dose prophylaxis (approximately 5 base mg/kg weekly) On the basls of these 
concerns, a senes of studies was conducted to examine the problem of malarla in pregnant women effective 
interventions and a means of improwng delivery of the interventions Studies were conducted to examine the 
prevalence of infect~on rlsk groups consequences of lnfection the efficacy of the recommended CQ 
chemoprophylaxls (see I1 D 2 b ) and the compliance of pregnant women to the regimen5 (see I1 D 3 c ) 
Study findrngs 
Prevalence of parasltemta In pregnancy Dunng a 2 5-year penod at the lakeshore slte of Mangochi D~strict 
44 5% of pregnant women were parasitemic at the time of their first ANC wsit Women in their first or second 
pregnancies women pregnant dunng the high transm~sslon season and those not using any prophylaxis were 
more likely to be parasitemlc than their counterparts Reported recent fever was not a good predictor of which 
women were parasitemlc and clinical illness was not a prominent feature associated with malana Infection 
Frequency of low bwth tvelght (LBW) A mothers malaria infection may cause her baby to be born with LBW 
(<2 500 grams) Its frequency was high In the population 16 6% of bables were LBW Low b~rth weight was 
observed in 28% of first-borns, 16% of second borns, and 1 0  12% of bab~es of higher birth order LBW was the 
strongest risk factor for infant mortality causlng a 4 fold increased risk of mortality in LBW babies compared wlth 
those of normal blrth welght 
The Mangocht Malana Research Project a 3 year longttudlnal study was undertaken to determ~ne the effect of malana prevention with an 
efftcac~ous anttmalarial on placental malana mfectton and low btrth weight Its des~gn and methods have been discussed m detatl elsewhere 
(Steketee et al 1993d) 
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Impact on polzcy 
These findings clarified the extent of the problem of malana among pregnant women A high prevalence of 
infection was seen in pregnant women, parhcularly those in their first and second pregnancies A high frequency of 
LBW was observed, particularly in first- and second-born Infants This led to consideration of a change In the 
nahonal policy to target rnalana prevention to women in their first and second pregnancies only In addition the 
finding that fever was not a good predictor of parasltemia reconfirmed that the intervention needed to be provlded 
to pregnant women wrthout regard to clinical findings such as fever 
II D 2 c Malar~a nd Infant mortahty 
The questrons 
To understand more completely the impact of malaria In infancy and to improve malaria treatment strategies for 
young children, the committee needed additional information on overall and cause specific infant mortality, includ 
ing an estimate of what proporhon of infants were dying outside health care facilihes From 1987 to 1989 popu 
lation based information on infant mortality was collected in the Mangochi Malaria Research Project (MMRP) this 
informahon was compared with health facility data from the nahonal HIS 
Study frndrngs 
Infant mortality The overall infant mortality rate in Mangochi District (a rural area) was 163 per 1 000 live births 
The neonatal (birth through day 28) and postneonatal (day 28 through day 364) mortality rates were 49 and 11 1 
deaths per 1 000 live births respectively 
Cause of death The spec~fic cause of death In the neonatal perlod was frequently not able to be determined 
Among reported deaths wth specific symptoms illness consistent with sepsis/tetanus was most frequent (19%) In 
the postneonatal period symptoms consistent with malana were the second most commonly reported cause of 
death (19%), only symptoms consistent with gastroenteritis (39%) were reported more frequently 
Duratlon of rllness The durabon of the illness prior to death was generally brief Information obtained from the 
parent or caretaker of the 1 child demonstrated that 70% of the deaths occurred wthin 7 days of the onset of 
illness, 38% died within the first 3 days Only 6% of deaths occurred after a reported Illness of more than 1 month 
Locatton of death Nearly two thirds of infant deaths were reported to occur at home, the rest occurred at a health 
care facility Of the neonates who died 53% died at home, this proporhon increased to 70% among infants in the 
postneonatal period Almost two-thirds of reported deaths due to fever/malana respiratory disease gastroententis 
measles and sepsis occurred outside health care fac~lihes 
Impact on polzcy 
Information from the MMRP and the HIS helped define the full impact of the problem of rnalana These data 
documented the high infant mortality occurring In rural Malawi and prowded an estimate of the proporhon of this 
mortality attributable to malaria In addition the stnlung findmgs that most deaths in infancy occur very rapidly after 
the onset of illness and that for every death occurring at a health facility two additional deaths occur in the 
community highlight the importance of developing malana policy focused on addressing the need for prompt 
recognition and proper treatment of malaria in young chddren in the community settmg 
These data were considered in the formulation of 1990 National Plan for Malana Control These revised 
strategies to improve malarla control reflected the need to ensure prompt recognihon and treatment of malaria in 
Develop~ng the malarm control structure and polrcy 1984-1 989 
very young children at the community level In part~cular three approaches were arbculated to address this need 
First to ensure the availability of the appropnate anbmalanals at all levels of health care the need to strengthen the 
antlmalanal drug supply and distribution system throughout Malawi, particularly at the community level was recog 
nized Second the need to train additional community volunteers and village health workers as well health servlce 
delivery personnel in the effective management of malana was idenbf~ed Finally the need for increased efforts at 
education to inform the pubhc, particularly mothers or caretakers about recognition and effectwe treatment of 
malaria was acknowledged 
II D 3 Studies of malaria intervent~ons 
II D 3 a Parasitolog~c and clrnical response to antrmalar~al drugs 
The questrons 
The Ministry s concern about emerging CQ resistance and the lack of assessment of the effectiveness of the current 
malana policy led in early 1984 to a plan to evaluate systemabcally the current malana control policies and activl 
ties The plan included selection of six senbnel sites for ~ntensified malana study selection and training of malana 
surveillance teams and a series of field studies The main focus of these stud~es was to evaluate the paras~tologic and 
clinical response to antlmalanal drugs 
The methodology 
Sentinel suroelllance sites SIX sentinel sites two in each adm~nistrative region were selected as sites at which to 
evaluate parasitologic and cl~n~cal response to antimalarials (Figure 12) Three of the s~tes were near the lakeshore 
at alt~tudes of 200-300 meters where year round malana transm~ssion is intense three were at altitudes of 1 000 
1 500 meters where transmission decreases dunng the cold and dry winter months Each site had an inpatient 
facility with electricity ample space in the outpatient facility and a laboratory in which the malaria surve~llance 
teams could work 
Figure 12 Map of sentmel surve~llance sites, Malaw~ 
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Malana surve~llance teams In 1984 three regional malaria surveillance teams of three members each were 
formed Each team was composed of a clmical officer (a health worker with advanced training In clinical diagnosis 
and mlnor surgery), a laboratory technician, and a laboratory assistant Initial training of the surveillance teams 
consisted of a remew of malaria parasitology and epidemtology, patterns of resistance to anbmalarial drugs, and 
methods of in vlvo t e s h g  for resistance (Box 5) Special emphasis was placed on preparing thlck smears stainlng 
them with Giemsa, and ~denhfylng and quantifying parasites Training was divided between the classroom the 
laboratory, and the field the inibal CQ resistance testing at one sentlnel site was included as the field training 
activity 
Box 4 Measuring drug res~stance 
Recognmng drug reslstsnce 
Drug res~stance n malarra paras~tes IS generally ffrst noted by clrn~cians when patients fad to respond to the stan 
dard treatment regimen For chloroqurne deterrorafron m drug efficacy is a gradual process rn~trally only a few pattents 
are affected They may Improve symptomatically but parasrtem~a reappears wrthrn 3 4 weeks (RI, see chart below) In 
time a substantral proportion of the patrent populat~on will be rnfected wtth chloroqu~ne-resrstant P falcrparum, and the 
resrstance may be such that parasltemia does not drmlntsh at ail after treatment (RIII, see below) 
Measurmg drug reslstance 
The devefopment of drug resistance m a populatron of malarra parasltes c a n  be measured In VIVO (by noting inad 
equate responses to properly admrnrstered treatment) or In vltro (by measurrng the effect of varrous concentrations of the 
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Box 5 Methodology for In VIVO testing 
A modrfred versron of the standardrzed WHO In vrvo procedure was used In CCCD actrvrtres to test for resrstance to 
antrmalarrals In thrs versron a younger group of chrldren was examrned to reflect the actual at rrsk group rn most of sub 
Saharan Afrrca The test provrdes the clrnrcal and parasrtologrc response rnformat~on upon whrch polrcy can be based and 
rt also IS surtable for frequent use In Malawr because rt IS feasrble wrthrn the budgetary personnel and logrstrcs constrarnts 
of the MOH Because of the accuracy of results compared wrth In vrtro test results and because of the immedrate avarlabrl 
~ t y  of results for use In pol~cy formatron rn vrvo testmg became an Important means of mon~torrng resrstance in Malawr and 
In other CCCD countrres 
Table CCCD Mod~frcatron of WHO In Vrvo Test 
WHO 7 day in vwo test (Bruce- CCCD modrfied test 
Chwatt 1986) 
Ages of partrcrpants 6 14 years (usually) 
Parasrte levels 
Use of drugs 
Blood smears 
2800 asexual formslmm3 
(usually) 
No hrstory of antrmalarral drugs 
for 1 week Negatrve Drll 
Glazko urrne test for 4- 
amrnoqurnolrnes 
Thrck and thrn blood smears 
dally from Day 0 to Day 7 
weekly to Day 28 
Health status of patrents Asymptomatrc school chrldren 
Follow up Day 1 through Day 7 weekly to Day 28 
Number of patrents and analysis At least 30 persons but no 
defrnrte scheme 
c5 years 
r2000 asexual forms/mm3 
Negatrve Saker Solomon 
test for 4 amrnoqu~nolrnes 
Thrck and thrn blood smears 
Day 0, Day 2 Day 3t Day 7 
Day 14$ Day 28$ 
Preferentrally symptomatrc 
Excluded rf too 111 to be treated 
orally Axrllary temperature 
taken each vrsrt 
Day 2 Day 3t Day 7 Day 14* 
Day 28% 
Dlctated by statrstrcal samplrng 
using a modrfrcatron of 
sequentral analysrs§ 
+Day 3 follow up for those whose parasrte densitres on Day 2 had not decreased by 75% 
$Days 14 and 28 for assessment of hematologic response added rn later studres 
§Sample srze was establrshed to detect greater than 10% resrstance or less than 1% resistance w~th 90h  confrdence An rnrtral group 
of 34 chrldren was tested the sample srze was rncreased if the estrmated prevalence of resrstance fell between 1% and 10% 
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Study findings 
In vzvo testzng 1984-1 9 8 6  
Because reports from another sub Saharan African country indicated that CQ in a single dose of 1 0  mg base& of 
body weight was effective one sentinel site tested this dosage among 26  chddren under 5 years 8 (30%) of the 
children showed an RIII response (see Box 4 for explanation of resistance patterns) and 2 1  (84%) of the remaining 
children showed an RII/RI response Therefore, testing at this dose was discontinued and continued with CQ in a 
dose of 2 5  mg base& body weight at this site and the five remaining sltes 
Results of testing children under 5 years of age and children between 5 and 1 0  years of age (Table 1) showed 
that CQ at the full curative dosage of 25  mg base& was not effective in eliminating parasitemia in a majority of 
children under 5 years of age, but that there was a trend towards greater CQ effectiveness among older chddren 
The studies suggested that an RIII pattern was present in 1984 among 8 5% of children less than 5 years old 
Although many individuals remained parasitemic on Day 7 the parasite densities among all but those wth RIII 
patterns were markedly decreased by Day 7, and 92% of children under 5 who were febnle at the start were afebrile 
on Day 7 Older children had lower rates of resistant parasites no cases of RIII were observed 
Table 1 P falaparum therapy fa~lures to chloroqume 25 mg baselkg, In vlvo testmg, ma law^, 
1984-1 986 
Rlll pattern of Farlure to eliminate 
resistance on Day 2 parasites by Day 7 
Part~cipant Number w) ("/.) 
Ch~ldren < 5 years 246 8 5 57 
Ch~ldren 
5 10 years 
Resistance to CQ was shown to be widespread In the country as shown In F~gure 13 of the results from the SIX 
sentmel surve~llance sltes 
Developrng the malarra control structure and polrcy 1984-1 989 
F~gure 13 Percentage of chlldren less than 5 years of age w~th demonstrated chloroqume res~stance 
(combmed RI,Rll,and RIII), by sentmel surveillance testmg s~te, ma law^, 1984-1986 
II D 3 a (11) Efficacy of second-l~ne ant~malar~als 
In vzoo testzng 1984-1988 
In vivo testlng at the sentlnel ates was also conducted for second line antimalanals AQ (10 mg/kg and 2 5  mg/kg) 
and SP6 (25 mg sulfa/kg) later mefloqulne (MQ) (15 mg/kg) and halofantrine (24 mg/kg) Additional thick smears 
were collected on Day 1 4  and Day 2 1  for the two second line anbmalarials AQ and SP (Heymann et a1 1987) 
(Table 2) AQ and SP appeared fully effective however 34% of children receiving AQ were parasitemic 21 days 
after therapy Resistance rates to AQ among children under 5 years appeared lower than to CQ 
One tablet of 5P IS a flxed combmabon of 25 mg of pynmetharnme and 500 mg of sulfadox~ne SP IS dosed at approximately 25 mg& of the 
sulfadox~ne component 
20 
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Table 2 Results of In vwo testmg to second-lme ant~rnalanals, ma law^, 1985-1988 
Parasrtemrc ch~ldren (%) 
Partlcrpants (ch~ldren 
Ant~malar~al (dosage) < 5 years) Day 7 Day 14 Day 21 
Amod~aquine (I Omglkg) 
smgle dose 
Amodiaqume (25 mglkg) 
divided dose 
Sulfadoxme pyr~methamme 
(25 mg sulfalkg) slngle dose 
Mefloqu~ne (25 mglkg) 
s~ngle dose 
Halofantnne (24 mglkg) 49 0 4 n t  
d~v~ded dose 
*n t = not tested 
II D 3 a (111) Eff~cacy of qulnlne used for severe ~llness 
Qulnrne was the standard treatment for severe and complicated malana In Malaw1 baseline data to confirm 100% 
efficacy of qunine treatment was requred for its continued use Qunine ln an 8 hourly dose of 1 0  mg& was 
tested at one of the sites among 2 5  children under 5 years of age who were admitted to the pedlatrlc ward w~th  P 
falcparum infections of >20 000 parasites/mm3 The children had 12-hourly thick smear examinations to deter 
mine parasite clearance time (1 e , the time when the first of two consecutive thick smears had no parasites) 
Parasite clearance times ranged from 36 to 1 0 8  hours with a mean of 67 hours, all children became parasite free 
I1 D 3 a (IV) Cl~n~cal response to antlmalar~al drugs 
The questron 
Dunng the lnltial evaluat~on of CQ eff~cacy the study team observed that although parasite clearance was subopt~ 
mal, most mdlvlduals (children and adults) improved clinically followng CQ therapy While this led to continued use 
of CQ as the first-line antrmalanal In Malaw1 evaluahon of the cllnlcal response to ant~malar~als was carned out to 
further understand thls Issue 
Study frndrngs 
Clln~cal response to CQ and SP Twelve cllnlcal signs and symptoms that had frequently been associated wth  
P falcparum infection were exarnlned for correlahon w~th  the dens& of parasltem~as (Pappiaoanou et a1 1991) 
Three of the clin~cal indicators were present m at least 75% of children with P falcrparum mfect~on and correlated 
with paraslte dens@ hlstoy of fever durlng the preceding 4 8  hours histoy of altered activity level dunng the 
preceding 48 hours and axlllay temperature >37 2°C These three indicators were used to compare chddren s 
clinical response to CQ and to SP  By Day 2 CQ was shown to have a more rapid effect in alleviating symptoms 
consistent wlth ~ t s  more rapid schizonticidal activity and 1t.s antipyretic effect By Days 7 and 14 however cllnlcal 
fadure rates for CQ were not significantly hlgher than for SP though considerable numbers of children in both 
groups remalned I (Table 3) 
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Table 3 Cl~n~cal response to chloroqulne and sulfadoxme-pyrimethamine, measured by three cllnlcal 
~nd~cators, Malaw~ 
Part~c~pants - >1 of 3 clrnical ind~cators present 
Ant~malarial (ch~ldren 
(dose) <5 years) Day 0 (%) Day 2 (%) Day 7 (%) Day l4(%) 
Three of the 126 ch~ldren were excluded from the study between Days 2 and 7 because of persistent h~gh fever and treated w~th 
amod~aqume 15 of the remalnmg 123 were excluded from further analys~s and treated between Days 7 and 14 
Cllnlcal response to qurnrne Axlllary temperature was selected to monitor the time to fever clearance during in 
vlvo testing of quinine (see study descnbed above) Fever clearance time was defined as the time when the axlllary 
temperature first fell below 37  5" C and rema~ned below this level for 4 8  hours The mean fever clearance tlme 
after treatment w~th qu~nlne was 36  hours (the range was between 1 2  and 72  hours) the mean parasite clearance 
bme was 67  hours 
lmpact on polrcy 
On the basis of the findmgs from these in wvo stud~es a malaria therapy policy was established in 1985 that 
endorsed the 1983 decision to discontinue routine chemoprophylaxis for children less than 5 years old and recom 
mended immediate presumptive treatment of fevers using CQ in a dose of 25mg base& Although parasite 
resistance to CQ had been demonstrated CQ remamed the drug of choice because of ~ t s  efficacy in reducing clinical 
illness in the 7 days after therapy its wide availab~lity and general safety A dose-for age chart showng correct CQ 
doses for age was developed for use in all health facilities and by other health care provlders (wllage health workers 
and TBAs) 
Because of their superlor effecbveness among children under 5 years who had high levels of CQ resistant P 
falcrparum AQ and SP  were recommended as therapy for CQ treatment failures It was further recommended that 
suspected chloroquine resistant ~nfections be evaluated by thrck smear before beginning alternative treatment a1 
though this was possible only at the larger health faclllties 
II D 3 a (v) Reevaluation of rn v~vo response to antimalarials 
Study frndmgs 
In~tial CQ AQ and SP resistance testing was completed in 1984 and 1985 In 1986 and 1987 in wvo response 
to CQ (25 mg base&), and SP  (25 mg sulfa&) was reassessed to monitor changes In P falcrparum response to 
these drugs (Figure 14) AQ had a significantly poorer Day 7 response compared wth SP suggesting that resistance 
to antimalarials in Malaw1 was contin~ung to intenslfy 
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F~gure 14 Changmg In v~vo response to ant~malarlals lnltlal testmg vs reassessment, ma law^, 
Chloroqulne Day 7 Amodiaquine Day 7 Sulfadox pyr Day 7 
lnltlal assessment Reassessment 
Impact on policy 
The changes in parasite response measured by repeat in vlvo testing were not considered sufficient to warrant 
a change in the treatment policy in view of concurrent studies of clinical response to antimalarials However 
because continued evoluhon of drug resistance was anhcipated m Malawi a policy of routine reassessment of P 
falclparum response at the sentlnel sites was recommended, with immediate in vlvo testlng if unsolicited reports of 
change in clinlcal response to treatment were received from anywhere in the country 
Study frndrngs 
Efflcacy of prophylaxls wlth CQ CQ efficacy was examlned among pregnant women who were given weekly 
prophylaxis under observahon in a dose of 300 mg base (the Nabonal Policy) to determine the effectiveness of CQ 
in keeping peripheral blood and placentas free of P falc~parum parasites (McDermott et al 1988) Seventy-three 
women who had either no initial P falclparum parasitemia or initial parasitemia that had cleared after treatment 
wth  CQ or AQ (25 mg/kg) were followed from early in the second tnmester of pregnancy untd delivery with thick 
smears every 2 weeks Among these 7 3  women 25% had P falcrparum parasites detected at some time during 
prophylaxis The geometric mean paraslte density of breakthrough mnfections was 145  parasites/mm3 paraslte 
patency was asymptomatic among 89% of the parasitemic women and the majority of women who had parasite 
breakthroughs were observed to clear parasitemias spontaneously during continued prophylaxls Thlrty suc women 
in the group delivered in hospital and had placental specimens collected These women were much less likely to 
have had evldence of achve or past infechon compared wth  women delivering at the same hospltal but not enrolled 
in the study 56% vs 92%, respectively (p=O 0005 chi-square) 
Efficacy of antlmalarral treatment In pregnant women In 1987 antimalarial treatment with CQ AQ and SP  
was examined in pregnant women using a standard in vivo drug sensitivity study methodology (Table 4) CQ was the 
least effective wlth 21% of women havlng persistent parasitemia on Day 7 
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Table 4 In vrvo test results of P falcrparum res~stance to chloroqu~ne, amodraqume, and sulfadoxme- 
pyr~methamme In pregnant women, Malawr, 1987 
Paras~tem~c Paras~tem~c Paras~tem~c Paras~tem~c 
Number of l n ~ t ~ a l  on Day 7 on Day 14 on Day 21 on Day 28 
Drug tested (dosage) women GMPD* N (%) N (%) N (%) N (%) 
Chloroqulne (25 rng 33 31 88 7 (21) 8/31* (25) 9/31 (29) 12/28 (43) 
baselkg) 
Sulfadoxlne 
pyrrrnetham~ne 38 3677 0 0 0131 0124 
(25 mg sulfalkg) 
GMPD = geornetrlc mean paraslte denslty 
** The number of women followed for 2 14 days vaned due to dellvery or loss to follow up 
In 1988 in vlvo studles unth 21 day follow up of MQ efflcacy in pregnant women showed results similar to those 
seen in studies of the highly eff~cacious SP  
Impact on polrcy 
The results of evaluation of both treatment and prophylactic doses of antimalarials demonstrated that CQ was 
not opt~mally effective for elther type of drug use In pregnant women m Malawi This led to the development of the 
MMRP to examine malaria prevention efforts In pregnancy (see Box 6) These results also established a knowledge 
base among MOH staff and an environment that would be responsive to new information regarding an effectwe 
intervention dunng pregnancy - settlng the stage for new policy decisions wlth the complet~on of the MMRP and 
further evaluation of other drugs 
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Box 6 The Mangochl Malar~a Research Project (MMRP) 
In a Fongrtudmal study conducted from September 1987 through June 1990 4 220 pregnant women were enrolled 
m four antenatal chnics n Mangocht D~strrct and assrgned one of four reglmens of ant~malarral treatment andlor 
chemoprophylaxrs 
-1 Ghloroqurne (CQ) treatment dose of 25 mg basefkg as admded dose over2 days followed by 300 mg weekly 
2 CQ treatment dose of25 mg baselkg as a drvrded dose over 2 days and repeatedevery 4 weeks 
3 CQ 300 mg base weekly (Malaw1 Natlonal Policy) 
4 Mefloqurne (MQ) treatment dose of 750 mg as a srngle dosefoilowed by 250 mg weekly 
Each dose of med~cat~on was gwen under obseruat~on by a study team member erther at the cllntc or at home the 
women were followed at4-week ~ntervats until delrvery after whrch mothers and rnfants were seen approximately 
every 2 months 
Af-rrsk groups The study confirmed earlrer frndtngs that pregnancy number was an important determmant of 
malana Infection m the women her pfacenta and the umbtkal cord blood of the newborn with prlmrgravldas 
carrying the highest r~sk The study also found the tncrdence of low birth werghf (LBW) by parttygroup to be hlgher 
for babres born to women w~th ~lacentai malarra lnfeciron than forthose without placental malarla The assoaatron 
between placental malarra mnfection and I-BW n flrstboms was strongest among women whose &rrd tnmester of 
pregnancy was exposed to hrgh malar~a transm~ss~on dunng fhe rarny and early postralny season 
Efficacy of antimaIar&s m cleamng pIacenta1 mfectlon Mefloqulne was much more Ltkely than CQ to ciear 
placental ~nfection Of the prrmrgravrdas assrgnectto one of the CQ reglmens 46% had placental malarra lnfectlon 
compared with 9% of the prrmtgravtdas receivng MQ MefEoqurne was more effective among multigravrdas as well 
15% recelvlng CQ and 3% recefvmg MQ had placental malarra rnfect~on fn each parity group the incidence of 
LBW was fowerfor women who had no placental malara regardless of the drug used to keep the placenta parasite 
free 
Effrcacy of anfmalarrals m clearing perrpheral rnfecfron Perasttemta at del~ery was 23 4% m pnmigrmdas 
15 7% rn secundigravidas and 10 2% In muttrgrawdas The perrpheral parastemla rate m women gwen CQ was 
more than five trmes that of women given MQ, contwrnmg the markedly different efftcacy of the two drugs 
Llrnb~Iicalcord blood tnfecfion UrnbrlcaI cord blood malaria rnfectron was ldentifred In 6 7% of newborns and 
was correlated wrth the densty of pfacental malam rnfectron urnbrlcal cord blood malarta was associated w~th 
preterm LBW 
LBW and survtval LBW was found to be a mqor determ~nant of neonatal and infant survival Compared w~th 
babres of normal birth werght bab~es born In the lower werght groups of 2 000 2 499 grams f 500 1 999 grams 
and below 1 500 grams were 2 4 11 5, and 27 1 times more l~keiy to dle tn the neonatal penod infants born wrth 
LBW had a 1 4 fold hgher rrsk of dying rn the postneonatal perrod thantherrcounterparts of normal birth wetght In 
this study mafartarnfectton m pregnancy was found to account for as much as 12% of LBW bab~es 
Impact of tke MMRP on pol~cy 
The MMRP showed ha1 a program of chemoprophyEaws for pregnant women wrth an efkacrous drug could be 
successful m reducrng a s~gnlfmint amount of LBW After discuss~ons of the results of the MMRP at the 1991 
natrortat rneetrng m Mangochi the Nat~onal Malaria Control Committee dec~ded that CQ should be replaced by a 
more effectwe drug fbr malana preventron dunng pregnancy Although MQ had been found effectwe ~t was not 
feasrble for national use due to rts cost and lack of availabilrty The comm~ttee mltiated stud~es to select an alferna 
We ant~malanal for a nabonat program of malana prevention (Sect~on I1 D 2 
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II D 3 c Treatment of severe malar~a 
The questions 
Although gu~delines for the management of cerebral malana had been establ~shed In the 1985 Nat~onal Malaria 
Plan Important unresolved issues in the understanding of cerebral malana and its treatment remained Flrst the 
lack of a un~form slmple and pract~cal method to assess the seventy of impa~rment of consciousness among 
chlldren w~th  cerebral malarla hindered comparison of the efficacy of different ant~malarial regimens Second 
prognost~c factors for adverse outcomes In children with cerebral malarla were poorly understood Thlrd ~t was 
unclear to what extent the decreased plasma glucose frequently observed in cerebral malaria was related to malaria 
disease or to quinine Induced hypoglycem~a (Box 7) Finally further lnformat~on was needed concerning the proper 
dosage and admlnistrat~on of parenteral quinine in children wlth cerebral malana These Issues were addressed 
through research conducted in the Malar~a Research Project at the Department of Pediatrics at Queen Elizabeth 
Central Hospltal (QECH) in Blantyre from 1986 to 1988 
Study findings 
Unlform measurement of ~Ilness everlty To provlde a unlform method of measunng the level of obtundation In 
children w~th  cerebral malana a grading system was developed based on mod~fications of the Glasgow scale used 
for unconscious adults (Teasdale and Bennett 1974) T h ~ s  modification uses motor and crylng responses to pain as 
well as the abil~ty to watch or follow objects to grade the seventy of depression of consciousness In v e y  young 
preverbal ch~ldren (Molyneux 1989b) The Blantyre coma sconng system has been widely adopted by cerebral 
malarla researchers throughout the world (WHO 1990) 
Rlsk factors for adverse outcomes Among children admitted to QECH w~th  cerebral malana cl~nical signs (e g 
profound coma convuls~ons at the time of admiss~on) as well as laboratory indicators (e g hypoglycemia 
hyperparasitemla) were assoc~ated w~th  a poor outcome Flfteen percent of children died and 9% were left with 
neurologic sequelae A prognost~c index based on some of these rlsk factors more accurately predicted outcome 
than any single feature These data helped to elucidate the natural history and prognosis of cerebral malana Use of 
the Blantyre coma scale enabled researchers to compare the seventy of cerebral malana among groups of chlldren 
to evaluate vanous therapies 
Box 7 Hypoglycem~a nd cerebral matarla 
Hypoglycemra IS common In chrldren w~th severe falcrparum malarra and IS assocrated wrth rncreased mortahty 
(Whlte et al 1987) Prelrmrnary data had suggested that rntravenous qurnne rnfuslons caused excessrve rnsul~n 
secretron and hypoglycem~a {Ok~tolonda et a1 1987) The Importance of hypoglycemra and the questron of whether 
qurnrne rnduced hyperrnsulrnemra occurs was evaluated In chrldren w&h cerebral malarla at QECH (Taylor et al 1988b) 
Among patrents w~th pretreatment hypoglycem~a 37% dred and 26% had neurologic sequelae In contrast among 
norrnoglycemrc chrldren only 4% dred and 7% had resrdual sequelae The worst prognosis was assocrated wrth recur 
rent hypoglycem~a No ch~ldren who were normoglycemrc on admrssron became hypoglycemrc during treatment wrth 
rntravenous qurnlne Hypoglycemla durrng qulnrne treatment occurred only among ch~ldren who were hypoglycemrc on 
admrssron and rt was not assoclated w~th yperrnsulrnemra 
Informatron from these stud~es documented that hypoglycernra was a common and serlous complrcatron of 
cerebral malarla rn Malawran chlldren and provrded reassurance that slow rntravenous qurnrne rnfusron to chrldren on 
marntenance therapy w~th glucose drd not contrrbute to the rrsk of subsequent hypoglycemra 
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Quinine route of administration and dosage Although Intravenous quinine is recommended for treatment of 
severe malana children with cerebral malaria may lnrtially present at peripheral health centers where intravenous 
therapy may not be available In such situations, administrabon of intramuscular quinine might be a practical 
alternatlve, however, the efficacy, safety, and pharmacohnetics of intramuscular quinine In children with severe 
malaria were largely unknown In a study of children with severe malaria at QECH, patients treated with intramus- 
cular qumine (initial dose10 mg/kg body weight) cleared their parasitemla and had no significant adverse clinical 
effects (Mansor et al 1990) 
Because cerebral malaria can be rapidly fatal it is important to achieve effective plasma quinine concentra 
tions quickly and safely Questions remamed about how quickly effective quinine blood concentrabons were achieved 
with the 1985 National Malana Plan regimen of 1 0  m g k g  body weight every 8 hours Previous research had 
suggested a loading dose of quinine (20 mg/kg body weight intravenously over 3 hours) might be beneficial, but 
there were concerns about the potential toxlcity of such a regimen in severely ill children (White et al 1983) 
Pharmacokmetic and clinical s i d e s  conducted at QECH showed that loading dose therapy resulted In rapid achieve- 
ment of effecbve plasma quinine concentrations and was not associated with undue risk of toxicity (Taylor et al 
1988b) A more rapid rate of quinine infusion (1 hour) was associated with relatively increased plasma msulin levels 
and a potentially Increased risk of hypoglycemia compared with the standard infusion rate (Molyneux et a1 1989c) 
Impact on pol~cy 
During 1988 and 1989, the data from the QECH Malana Research Project were presented and discussed in 
meetings with MOH and other medical personnel throughout Malaw, and at the national meeting in Mangochi in 
1991 As a result of these discussions, the national malaria gudelines were revlsed The recommended manage 
ment of severe malana was modified to reflect the newly available informabon in the following ways 
1) Patients with severe malaria diagnosed in the outpatient setting should be treated with intramuscular 
quinine in a dose of 1 0  mg per kg body weight to be repeated at 4 hours and every 1 2  hours thereafter 
until transport to a facility where intravenous therapy is available 
2) Hypoglycemia should be acbvely evaluated and corrected, 
3) In inpabent sethngs, quinine therapy should be initiated wth  a loading dose of 20 mg/kg body weight 
glven intravenously over 3 hours, 
4) Dunng therapy, the degree of impaired consciousness should be monitored wth the Blantyre coma scale 
assessment, and 
5) After recovery, the chdd should be assessed 2-4 weeks post hospitalization for neurological deficits and, if 
appropriate physiotherapy should be inibated 
II D 4 Stud~es of malar~a treatment and prevention pract~ces 
II D 4 a Malarla treatment and prevention practrces In the community 
The questzons 
To help design methods of prowding CQ at the community level through the PHC system current treatment 
practices m the community were studied Several small scale PHC projects, sponsored by the ACSI CCCD Project 
and other organizations, were established Evaluations were conducted to determine the proportion of those with 
malana treated at home (versus health facility), correct treatment with CQ at home and the acceptability of TBA- 
based treatment in communities 
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Study findrngs 
Home treatment Two surveys and a special sentinel surveillance system7 prowded information about community 
pracbces nationally and in Sallma Distnct along the lakeshore Esbmates from two surveys of the propohon of 
children who were treated at home for malana ranged from 31% to 54% The surveys and surveillance system 
showed that CQ and anbpyretics had been given to only a minonty of febnle children Eight to fifteen percent of 
chlldren under the age of 5 years who had fever/malana withln the prewous 2-week penod had been treated at 
home with CQ, and 1% 18% had been treated with an anbpyretlc 
Acceptab~lrty of TBAs as commun~ty health provrders of CQ A study conducted in 47 wllages in Salima Dlstrict 
showed that TBAs could safely provlde CQ treatment In the community TBAs in one third of the vlllages (study 
dlages) were tralned In the presumptwe diagnosis and treatment of fever/malaria and glven a supply of CQ 
Meanwhile health staff in all health facilibes sennng the wllages were glven refresher tralning in the diagnosis and 
treatment of malarla Study wllage chiefs admsed community members that they could receive free treatment m the 
community from a TBA After 6 months, 56% of the women in the study vlllages and 5% of the women in the 
control villages consulted a TBA for malana treatment for thelr chlldren TBAs provlded correct doses of CQ to 
92% of the children they saw while correct doses were recorded for only 18% of the children treated by health 
workers (p<O 0001) However to use TBAs to dellver CQ in the community requlred more funds for their training 
and supemsion 
Impact on pollcy 
Although the GOM 1 0  year health plan recommended that an increasing proportion of all health semces be 
conducted In the community by mothers and community health workers (e g , vlllage health workers, TBAs), the 
overndmg concern of the Malarla Control Program was that fever should be treated promptly with an antimalanal 
While the above data do not reflect tlming of treatment, they do show that 50% 70% of all febnle chlldren were 
treated at a health facllity Nationwide at the community level few caretakers were using CQ and antipyretics in the 
home Thls findlng could reflect either lack of physical or financial access to CQ in the community or lack of 
knowledge of appropnate treatment of febnle lllness Attempts to improve CQ use in the community by equipping 
TBAs to be providers although successful in the study in Salima Distnct were costly and could not be sustained 
II D 4 b Outpatlent and mpat~ent reatment practrces 
The quest~ons 
To evaluate the extent to which health workers were complying wrth the new nabonal malaria treatment guidelines 
of 1985 and to provlde baselme data for monitonng health worker tralnlng outpabent and inpatient treatment 
practices were examined 
' Home treatment practices of parents and guardians whose chlld wth a fever or malana was belng seen at a health fachty were monitored through 
a speclal sentlnel survelliance system established m 1986 at 12 outpatlent faclllbes representahve of the geographic and climatic areas of the 
country A survelUance offlcer from each slte selected from among the hosp~tal cllmcal staff was tralned In Internew techmque senbnel reporhng 
and baslc data analysls dunng a 1 week tralnlng course Each sentmel fachty was prowded wth a preprinted reglster for recording dally surveillance 
lnformatlon about all chlldren under the age of 5 years presenhng wlth fever/malana Data on what treatment lf any was prowded before the child 
arnved at the health facility what treatment was glven at the health faclllty and whether the chlld was referred for admlsslon to an mpabent facillty 
were recorded 
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Study f~ndrngs 
Antrmalarral drugs and transfusrons admrnrstered as rnpatrent treatment At one of the sentinel sites, records 
were remewed for all children who were admitted dunng the years 1980 through 1986 with malaria as one of thelr 
discharge d~agnoses Treatment patterns in hospital reflected correctly implemented poky recommendatlons dur- 
ing the years 1984 to 1986 and were consistent wlth increasing use of oral antimalarial drugs other than CQ and 
use of oral CQ (in contrast to parenteral CQ) (Figure 15) The 50% increase in blood transfusions was consistent 
with increasing numbers of chddren being admitted with anemia 
F~gure 15 Recorded use of ant~malarlals and blood transfusion among hosp~tahzed ch~ldren w~th 
malarla, ma law^, 1980 and 1986 
Health worker practrces In an outpatlent facrlrty In one study 86 health workers were tramed in a refresher 
course in methods of diagnosis and presumptive treatment techniques and then evaluated 12  months later Al 
though 90% of the health workers prescnbed CQ for the children and 52% measured the child s temperature fewer 
than half asked the age of the child or gave the first dose of CQ in the health facility, and fewer than one in four 
prescribed the correct dose of CQ for age or gave an anbpyretic 
Impact on pol~cy 
Inpabent practices The Malaria Control Program recommended that monitoring of treatment practices be 
conbnued at this and other sentinel site hospitals Because of ~s record rewew the program recommended 
limiting the use of blood transfusion in children with malana whenever possible unbl safe blood supplies (1 e blood 
screened for human immunodeficiency mrus) could be ensured at all hospitals 
Outpatient practices Although refresher trammg of health workers appeared to result in health workers 
administering presumptive doses of CQ, workers did not gve the correct dose or give an antpyretic as an adjunct 
to treatment A recommendatlon was made to mod& refresher training to mclude practical experience However 
this recommendation was not implemented 
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II D 4 c Ant~malar~al use among pregnant women 
The questzons 
The effectiveness of antimalanal prevention dunng pregnancy relies on both the efflcacy of the drug (see above 
Section I1 D 2 b ) and the woman s compliance wtth the recommended regimen Increased understanding of com 
pliance and determinants of compliance among pregnant women was sought 
Study findings 
Compliance to antimalarial prophylaxis among pregnant women Although sufficient quantities of CQ tablets of 
150 mg base were provided to pregnant women attending ANCs to take the recommended dosage at home (two 
per week between monthly clinic visits), compliance rates were not high Eight hundred and two women attending 
ANC at four of the senbnel sites 160 of whom were on first vlsit, were asked to provlde a urine specimen to 
determine levels of CQ and desethyl chloroqume (Heymann et a1 1990) Of those women on fmt vlsit 20% had 
unne CQ levels compabble wth  ingestion of a CQ prophylactic dose (5 mg base&) during the preceding 7 days 
and 36% of those on return vlslt had compabble CQ levels (p=O 0002 chi-square) In addition to unne testing thick 
smears were collected from pregnant women at these same clln~cs and exarnlned for P falcrparum parasites 
Among 280 women on their first ANC vmt 40% had P falciparum parasites identified on thick smear while 
among the 728 women on return vlslt 31% had P falaparum infection 
Intervention efforts to Improve compliance wth CQ prophylaxis were conducted in four clinics In Lilongwe 
Dlstnct The three interventions used (improved health education use of a sugar-coated CQ tablet to eliminate the 
bltter taste or both) were found to be associated wlth significant increases m Improved compliance wlth CQ lnges 
bon (Hehtzer Allen 1993a) 
Impact on polzcy 
These results suggested that poor comphance wlth home ingestion of antlmalanals was a major impediment 
to the effectiveness of the program In fact the overall effectiveness of antenatal CQ prophylaxls programs in 
Malawl was determined to be less than 10% of the maxlmum theoretical effecbveness, which is based on the use of 
a 100% efficacious drug and 100% compliance These results suggested to MOH officials that any reglmen that 
used an antimalanal more efficacious than CQ and that reduced the effect of poor comphance (e g simpler dos~ng 
regimens or In cl~nlc dosing only) would be much preferred over the exisbng regimens whlch requlred home 
ingestion of CQ 
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II E Impact on stud~es on pohcy a summary 
From 1984 through 1989, data collected and evaluated from rouhne monitoring systems (the 
national HIS), special surveillance systems (e g , malaria sentinel surveillance), and a serles of field stud- 
ies provided both baseline information on the malaria situat~on in Malawi and important information on 
which to base policy and program strategies Th~s  information was summarized by topic in the previous 
section, and some of the chief points are highlighted below 
The problem of malar~a The documentation of high malaria-related morbidity and mortality in 
the early prevalence studies and through the HIS provided support for the mtense control efforts ex- 
pended by the GOM and the international community Studies of the problem of malana were able to 
provlde justification for the target groups children under 5 years of age and women m their first and 
second pregnancies Studies showing the latter group at greater risk than women in later pregnancies 
led to changes at the national level in the prior~ty given to malaria treatment and prevention among 
pregnant women Prevalence surveys revealing increasing rates of anemia in hospitalized young chil- 
dren consMuted an addihonal argument for the need for continued reassessment of the efficacy of the 
first-line anhmalarial 
Malana ~ntervent~ons Clinical and parasitologic responses to CQ obtained from in uvo studies 
throughout the country provided essential information for pol~cy formulat~on and reusion and the devel- 
opment of standard treatment guidelines On the baas of flndings from these studies, the 1985 policy 
recommended halting routine chemoprophylaxis for children less than 5 years old and treating fever 
presumptively wrth CQ in a dose of 25 mg basekg Although CQ was decreasingly effective in clearlng 
parasites, 1984-1986 data on clinical response indicated that it retained ~ t s  effectiveness in reducing 
symptoms Because it was clear that CQ resistance was increasing, a policy of routine reassessment of 
response was recommended Studies showing that CQ was not optimally effective for pregnant women 
in either a treatment or prophylactic dose led to the examination of more effechve antimalar~als, SP and 
MQ Although MQ was used as a h~ghly effective antimalarial drug for pregnant women in a large study 
in Malawr (MMRP), it was understood that it could not be recommended for national policy because of 
its expense and lack of availability, and the committee initiated additional studies to examine a poten- 
tially effective, safe, and affordable alternatlve antimalar~al 
Malarta pract~ces Studies found that children were not being treated correctly at home or at 
health facilities The malaria control program then attempted to improve community CQ use by equip- 
ping TBAs as prov~ders, a strategy that, while effective, was too costly to be sustained The program 
also recommended ongoing monitoring of malaria treatment at health facilit~es and providing refresher 
train~ng to workers Pregnant women s compliance with a reglmen of antimalarial prophylaxis was 
poor, chiefly because the drugs had to be taken at home These data laid the foundation for MOH 
commitment to find a more effective regimen that would reduce noncompliance as an ~mpediment o 
program effectiveness 
Early operational research yielded these lessons 
A systematic approach toward policy, strategy, and guideline development was critical for the 
orderly development and success of a nat~onal policy, plan, and program These steps included 
a) engaging decision makers early in the process, b) gathering important informat~on on the 
problem of malaria, the efficacy of interventions, and exist~ng patient and health worker prac- 
tices, c) establishing a formal national program wth an oversight/advisory committee with clear 
organizahon and responsibilities, d) elaborating a national policy and plan, e) developmg and 
d~sseminating treatment and prevention guidelines, f) preparing health education and training 
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materials, and g) convening broad-based meetlngs for consensus building on pollcy and pro 
gram planning and informabon dissemination 
Documentation of the problem was important it prowded an opportunity for the natlonal 
program staff to develop experience In baslc malaria issues, and it showed senior officials and 
donors the extent of the problem and ~ t s  relative importance In Malawl The information also 
prowded a baselme against which progress could be measured However, documentation of the 
problem alone was not suffment to engender support for malarla control efforts Ewdence of 
success wth mterventions was lacking, and the Ministry and donor community had not strongly 
committed resources (personnel or money) to address the problem 
Because the National Malarla Control Pollcy adopted strateyes based principally on the thera- 
peutic and preventwe use of anhmalarials, it remalned important that the efficacy of these 
interventions be monitored 
It IS In the area of practices (health worker, patlent, and caretaker) that the majority of short- 
comings In program effectiveness were documented At the same tlme, whde improvements In 
these areas were recommended, their implementation was limited by shortfalls in resources - 
particularly for tra~nmg, refresher training, and supems~on 
Evaluating and Refining the Malaria 
Control Policy and Program: 1989- 1993 
'Part III Evaluahng and refining the malaria policy and program 1989-1993 descnbes the exter- 
nal evaluahon of the first 5 years of the malaria control program and the subsequent history of Malawi s 
process of policy and program development As in Part 11, the studies reviewed are categorized by focus 
problem, interventions, and prachces 
Ill A Summary of malarla program and pohcy accompl~shments 
In 1989, Malawi's malavla control program was evaluated by a group composed of Malawians 
from the MOH and nongovernmental organizations and external consultants from international organi- 
zations The shortcomings identified, chiefly in the area of program implementation, led to a revised 
control plan for 1990-1994 In addihon, on the basis of studies of anhmalanal efficacy in children under 
5 and pregnant women, the program officially changed its first-line drug from CQ to SP 
F~gure 16 Malar~a program and pol~cy m~lestones 1990-1 993 
1990 1991 1992 1993 
Developed malaria control plan 
Approved malaria control plan 
Revised treatment gu~dellnes at nat~onal meeting In Mangochi 
Updated and prmted treatment guidelines 
Held meetmg with private sector pharmaceutical 
companies 
Conducted health educat~on mater~als development 
workshop 
Held reg~onal meetings ( 92 '93) to announce 
antimalarial change 
Implemented change In f~rst 
lme ant~malar~al drug 
Established system to track 
effects of SP 
Trained sent~nel surve~llance 
personnel 
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F~gure 17 Stud~es affectmg malar~a pol~cy development 1990-1993 * 
1990 1991 1992 1993 
Parameters to evaluate antlmalarlal efflcacy 
Cl~n~cal d~agnos~s and treatment of overlap malar~a nd pneumonia 
Assessment of malarra vectors 
Reg~men for preventmg malar~a in pregnancy 
Knowledge att~tudes, and practces malar~a In chlldren 
& pregnant women 
Econom~c ost of malar~a 
Evaluat~on of presumptive treatment and case 
defln~t~on f malar~a 
Time h e  shows the year In wh~ch the studies were begun 
111 B The 1989 evaluat~on of the f~rst fwe years 
In July and August 1989, an evaluat~on of the malaria control program was conducted Suc exter 
nal consultants from UNICEF, USAID and WHO, and 22 Malawians drawn from the MOH and nongov 
ernmental organizat~ons partic~pated In the evaluat~on The purposes of the evaluat~on were to deter 
mine whether the objectives for the first 5-year plan (1985-1989) had been achleved and to identify 
problems In achiev~ng the objectlves that could be addressed In the subsequent 5 years The evaluation 
cons~sted of ~ntervlews with officials at the MOH, hospltals and other health facihties, assessment of 
health worker job performance, health fac~lity record revlew, and a KAP survey For the KAP survey, 3 0  
clusters throughout the country were randomly selected us~ng the Expanded Programme on Immuniza- 
tion cluster sample survey methodology, and lnformatlon was collected uslng questionnaires and other 
forms developed for the evalualon Specif~c objectives were to 1) assess malana control actiwt~es In 
Malawi and determine the degree of success In achieving established goals, 2) Identify techn~cal and 
operat~onal problems, 3) determine solut~ons for accelerating implementation of malarla control strate- 
gies, and 4) develop guidelmes for the 1990-1994 ~rnplementat~on plan 
A 2-day training session was conducted to famihanze team members w~th procedures and evalua- 
tion materials Follow~ng the tralnlng, the rewew team was divlded Into five groups, each w~th at least 
one external consultant as team leader The groups wsited the three maln referral hospitals, 16 district 
hospltals, 3 0  health centers, and 870 households 
Assessment of success In reachlng goals Health facihty data showed that the objectives to reduce 
malaria morb~dity and mortality in Malawl had not been achieved From 1985 to 1988, under 5 hospl- 
tallzatlon increased by 43% hospital deaths grew by 85%, and malaria case fatality rates rose by 30% 
While the worsening of chloroqulne-res~stant malar~a was thought to be the major cause for fallure to 
achleve program objectlves, programmat~c and operational problems were believed to have contributed 
to l~m~tlng program success 
Programmatlc and operational problems ldenttfied The malaria control program suffered from four 
maln management constraints 
Operational plans did not exist at all levels The 1985-1989 ~mplementahon plan was seen largely 
as a strategy/pohcy document because it lacked a timeline for program implementation The 
regional and district personnel lacked a clear vlsion for planning, considering it ch~efly In terms of 
training activ~ties 
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Management personnel responsible for planning, implementing, monitoring, and supervising ma- 
laria control actiuties at the nahonal, regional, and district levels were insufficient in number, 
sometimes inadequately trained, and burdened with other responsibilities 
There was no budget for malaria control No record existed to show how much had been spent, 
how much was needed, or how much was available for malaria control at any of the three levels 
Supewisoy activities at all levels were sporadic, not carefully planned, and unguided by specific 
performance, standard, or target criteria 
Ineffectrve tralnlng Between 1985 and 1989, numerous malaria training activities were carried out, 
mostly for senior and midlevel managers from the national, regional, and district levels However, it was 
not possible to determine the effectweness of these training actiuties since there were no reports of 
these activities at each level of health delivery Some of the personnel carrying out malaria ac.hvities had 
no formal training, most lacked the expenence and slulls necessary to train others, and thus the content 
of training activities was not always adequately transmitted The sessions were often too short, highly 
didactic, wth little opportunity for practical work, and not followed by review, refresher courses, or 
supemso y visits Documentation of training and other program components was largely inadequate 
Inadequate health educat~on Malaria health education materials were developed by the Health 
Education Unit of the MOH, with assistance from the Healthcom Project, starting in 1986 More than 
a dozen innovative items designed to educate mothers and health workers were wdely distributed in 
all districts, and regional and district personnel participated in 3-day workshops on their use Despite 
this base of achievement, health educahon for the malaria control program experienced serious short- 
comings 
The use of the health education materials was poorly understood within the Health Education Unit, 
consequently, training in their use was inadequate In addihon, many health center personnel 
responsible for teaching mothers and pregnant women about malaria management and preven- 
tion did not receive any training in the use of these materials and in health education methods in 
general 
Behaworal research to support the development of the materials was inadequate in scope of en- 
quiry and regional coverage These weaknesses were thought to contribute to underutilization of 
the materials 
Outcome of evaluation The 1990-1994 malaria control plan was based on results of the evaluation 
and was designed to address the identified constraints This plan provided more details of program 
implementation and included a time line for major program activities A more extensive, nationwide 
KAP survey (discussed in I1 D 3 ) was conducted to better understand the community's awareness of 
malaria and to develop appropriate health education materials 
In 1991 and 1992, to address the severe shortage of technical assistance, two external experts 
were hired to provide technical support for the malana control program During the same period, two 
nationals were sent abroad for advanced traning The program appointed an additional health worker 
whose sole responsibility was malaria control management 
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Ill C Ref~nrng the malarra control polrcy and program 1990- 1993 
Guided by the 1989 evaluation, the second 5-year malaria control plan (1990-1994) was devel- 
oped in 1990 and approved in 1991 To reach its targets, the reduction of malaria-related mortality and 
morbidity by 1 0  percent and 20 percent, respectrvely, the plan identified ten necessarv elements 
Improved understanding of malaria illness, prevention, and treatment 
Accurate diagnosis 
Effecbve treatment 
Effective prevention in high-risk groups 
Alternative control methods 
Diagnosis, treatment, and reporting Incorporated into health personnel training 
Strengthened malaria reporting system 
Effective management and administrabon of the Malaria Control Program at all levels 
Increased research capability 
Increased GOM and donor investment in malana control 
For program acbvlties, a trme line was drawn up and the responsible office and support agency 
were noted where applicable Information was gathered, and actions were taken for each of these Items 
(Table 5), which are discussed further In Sectlon 111 D 
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Table 5 Stud~es  and act~v~t~es conducted to address the ten elements of the 1990-1 994 
nat~onal malarla control plan 
- - - - - - - - - - - - - - - 




Knowledge, att~tudes, and practces (KAP) survey to 
document exist~ng understand~ng and practices 
health education material development based on KAP 
fmdings 
Studies to examine d~agnost~c cr~ter~a and Improve 
clinical d~agnos~s of malar~a 
Studies to examlne cl~nical and hematolog~c outcomes as 
measures of effective treatment, change from chloroquine 
(CQ) to sulfadoxine pyrimethamlne (SP) as primary 
therapy for malaria* 
Effective prevention in hlgh rlsk groups Studies to examine feas~ble regimens for malar~a preven 
tion In pregnant women led to change In national policy 
for malar~a prevention In pregnancy 
Alternative control methods Assessment of malaria vectors b~t~ng hab~ts entomologic 
moculat~on rates plannmg for work w~th lnsectlc~de 
Impregnated bednets 
lncorporat~on of d~agnos~s treatment and ** 
reportlng Into health personnel training 
Strengthened malaria reporting system ** 
Effective management of malaria control program Nat~onal level increased staff training for a Malawian at 
all levels ep~demrolog~st wlth malar~a experience 
Regional level des~gnated responsible person for 
malarla control supervlslon 
lncreased research capab~l~ty Doctoral and masters level trainlng for two Mlnlstry of 
Health (MOH) staff w~th emphas~s on trainmg In malar~a 
control issues 
Increased Government of Malaw~ (GOM) and Econom~c assessment helped the GOM and donors 
donor mvestment in malaria control understand current expenditures MOH prov~ded financial 
comm~tment to change from CQ to SP donor interest 
increased but Investment amount not greatly changed 
*H~ghl~ghted In Box 9 
**As of the end of 1993 no activities had addressed this element 
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Ill D lnformat~on gathered and its effect on malar~a p o k y  
Ill D 1 Operational research agenda 1990-1993 
Because the program evaluation showed rapidly increaslng malana-related morbidity and mortality 
and weaknesses in program delivery, the malaria control committee sponsored additional studies to 
refine the malarla control policy and refocus the malarla control program 
The problem of malarra The difficulty in diagnosing malarla definitively on the baas of clinical 
features (laboratoy confirmation being generally not posslble due to lack of microscopy) and the fre- 
quently overlapping diagnosis of malarla and pneurnonla, another frequent childhood ~llness, led to 
studles examining the overlap of these two illnesses To further understand the role of alternative mea- 
sures for malarla control, an assessment of local malarla vectors was conducted, both to tram a cadre 
capable of monitormg vectors and to evaluate the feasibility of ~nsectmde-impregnated bed nets as a 
locally relevant control measure In addition, the committee recognized that to allocate scarce resources 
most wisely for effective interventions, the economic cost of malana to families and to the nation must 
be assessed 
Malana rnterventtons The conbnuing efflcacy of CQ was quesboned because anemia was be- 
coming an increaslng cause of hospital deaths among children Studies had shown that CQ was increas- 
~ngly meffectlve in clearing parasitemia, and perslstent and/or recurrent parasltemla was known to 
result in anemla Studies were then conducted to assess the current efficacy of CQ parasltologlcally, 
clinically, and hematologlcally and to determine whether an alternatlve drug (SP) would be more effica- 
cious Earller studies of the use of CQ in reglmens of treatment and prophylaxis among pregnant 
women had conclusively shown that CQ no longer retained sufficient efficacy, during thls per~od, the 
committee focused on finding an antlmalarial that could be used in a natlonwlde program of malaria 
prevention in pregnant women 
Malarla practices To launch the new first-line antlmalarial, practices of people in the community 
had to be explored-their beliefs about the disease and its treatment and their own actlons to prevent 
and cure malana With thls information effectwe health education messages could be designed, and 
subsequent pollcy changes could be monitored and evaluated 
The next sections revlew the results of studles conducted to evaluate the problem, ~ntervenbons, 
and practices The questlon(s) to be answered by the study and the study findings are followed by a 
summary of the effect of each study on Malaw's malaria policy 
Ill D 2 Studres of the problem of malarra 
I l l  D 2 a Case definlfion of malaria 
The questrons 
In Malawl and in most of sub Saharan Africa the nahonal policy for malana treatment is to presume that a person 
with fever or recent history of fever has malana and to provlde treatment wth  an antimalanal drug This presump 
twe treatment strategy developed In the late 1970s and early 1980s, was based on clinical rather than laboratory 
findings because m~croscop~c confirmation of malar~a parasitemia was rarely possible and even where possible 
prohibitwely expenswe At the same bme that effective therapy was being reconsidered (see IVD 2) the MOH 
began to reconsider the presumphve treatment strategy Three studies were undertaken to examine 1) the overlap 
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between the clinical diagnosis of malaria and acute respiratory infection (AH) in children, 2) alternative chnical case 
definitions for malaria in children, and 3) presumptive versus laboratory diagnosis of malaria In adults 
Ill D 2 a (I) Cl~n~cal diagnosis of malaria and ARI 
The ques t~on 
Malaria and ARI are the pnmary diagnoses for over half of the children seen as outpatients at health facilit~es in 
Malawi A fraction of children wth ARI have pneumonia and need treatment wlth an anhmicrobial drug A child 
with fever and cough may sahsfy the clinical definitions for both malana and pneumonia, but in a busy clinical 
sehng be assessed and treated for only one To determine the extent to which children who met the clinical 
definition for malana also met the clinical definition for pneumonia (a subset of more severe ARI) a study was 
undertaken at the outpatient department of Kamuzu Central Hospital during a season of high incidence for both 
rnalana and pneumonia (Redd et a1 1992) 
Study Endrngs 
Chlldren who met the cllnlcal and laboratory defrnrt~ons Of children brought to the hospital because of cough or 
fever and enrolled 61% met only the clinical definition for malana 28% met the definihon for malana and pneumo- 
ma, and 1% met only the clinical definition for pneumonia Almost every child that met the pneumonia case 
definihon also met the malaria case definition (Figure 18) 
P falc~parum parasitemia was detected in 35% of children and radiographic evidence of pneumonia was 
found in 8% Of the children wth radiographic ewdence of pneumonia 43/116 (37%) had coexisting P falc~parum 
parasitemia the remamder were aparasitemic 
F~gure 18 Overlap of malarla and pneumonia clinical case defln~tions and malaria paras~temia and 
rad~ographic evidence of pneurnonla 
Overlap of rnalar~a nd pneurnonla clln~cal case defmt~ons 
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Overlap In malar~a paras~tema nd rad~ograph~c ev~dence 
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The clinical definitions and laboratory findlngs overlapped substantially 95% of children meeting the clinical deflni 
tion for pneumonia also met the clinical definihon for malaria Children wth P faluparum parasitemia were as 
likely to have radiographic ewdence of pneumonia as those without parasitemia and were also as likely to have 
severe radiographic changes 
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Efflcacy of cotr~moxazole A 5 day course of cotnmoxazole at the standard dosage and durabon recommended 
for treatment of pneumonia was assessed for anbmalanal efficacy All chlldren that were followed for 1 4  days (96% 
of those enrolled) became aparasitemic at a mean of 2 7 days after the inlbabon of treatment with a mean fever 
clearance time of 1 5 days Children remained parasite free for the 1 4  day follow up 
The results were used to emphasize the need for health workers to evaluate children wlth cough and fever for 
both pneumonia and malana The findlng that cotnmoxazole was effectwe treatment for malana in children permlt 
ted the Nabonal Malaria Control Program to recommend m the 1992 Treatment Guidelines that a child treated with 
cotrimoxazole need not receive an antimalanal 
Ill D 2 a (11) Alternatlve cllnlcal case deflnrtlons for malar~a In chrldren 
The questzon 
The second study assessed the exlstlng clinlcal case definition used for presumptive therapy of malana and assessed 
alternative cl~nical case definltlons for the diagnosis of malana m chlldren at two sltes Mangochi Dlstnct Hospital 
and Nkhoma Hospital 
Study frndrngs 
Reported hlstory of fever Nearly 90% of children were reported to have had a febnle lllness by the mother and 
thus would have been treated presumptively for malaria, fewer than 40% had an elevated rectal temperature The 
discrepancy may be due to mothers erroneously identifying many illnesses as havlng a fever component or to 
children w~th  intermittent fevers belng seen during a period when their temperature was normal 
Sensrtrulty and spec1 flclty of clzn~cal case definztlons In evaluating case definlt~ons for malana and defining 
malaria as P falclparum infection of any density the nabonal policy was over 90% sensibve but only 21% specific 
(Table 6) The combmation of rectal temperature 2 37 7" C or splenomegaly or nadbed pallor three findings that 
were individually highly associated wth parasltemia was 85% sensitive and nearly 41% specifx Other findlngs and 
other comblnatlons were elther too lnsensltlve or too nonspeclflc to be used to decide whlch children to treat for 
malaria 
Table 6 Cllnrcal case deflnltrons to ldentlfy malarra parasrtem~a, wet season, Malawr, 1993 
Pos~t~ve 
predlctwe 
Defmt~on Sens~t~v~ty* (Oh) Speclf~crty"" (%) valuef** (%) 
Any hrstory of fever 93 21 63 
Compla~nt of fever 73 36 63 
Elevated rectal temperature 45 75 72 
Elevated rectal temperature or splenornegaly 70 59 72 
Elevated rectal temperature or splenornegaly or 85 
na~lbed oallor 
Sensltlv~ty refers to the proportlon of all ch~ldren w~th paras~tem~a who would be ~dent~f~ed usmg the glven defln~t~on 
Speclflcrty refers to the proportlon of all ch~ldren w~thout parasltemla who would be ~dent~f~ed by not meetmg the glven deflnrt~on 
Pos~t~ve pred~ct~ve alue refers to the proportlon of ch~ldren meetlng the glven defln~tron who actually have parasltemla Thrs proportlon may 
be affected dramat~cally by the prevalence of mfechon In the population 
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This assessment of alternabve case dehibons suggests that a combinabon definibon of objecbvely measured 
elevated temperature or enlarged spleen or pallor may be a better guide for antimalarial treatment than asking the 
mother if the child has had a fever The slightly lower sensitivity of this combination definibon means that some 
chlldren wth malaria parasitemia will not be identified Most children not idenbfied by these more restncbve defini 
tions had lower density parasitemias and hemoglobin concentrations not In the anemic range and thus would be 
expected to do well without specific therapy for malarla The advantages of a more restncbve definition are that 
fewer chlldren who do not have parasltemia would be treated for malaria This would result in substantial cost 
savlngs and would potentially delay the emergence of resistance to antimalanals such as SP 
Impact on polzcy 
The MOH 1s currently considering the results of this study and a possible follow-up study to evaluate the 
impact of a revlsed definition on the management of malana and determine whether parasitemic children who are 
not clinically considered to have malana by a more restncbve case definition will do well following discharge from 
the clinic without specific treatment for malarla 
Ill D 2 a (111) Clln~cal versus laboratory d~agnos~s of malar~a In adults 
The questron 
The third study was conducted at QECH in Blantyre dumg the 1993 rainy season to compare the costs of perform- 
ing microscopy on all adults with a recent fever h~tory  and treatmg only parasitemic persons with the costs of 
treabng all adults with a history of fever for malaria (the current policy) The study was conducted in 1 week phases 
Durlng phase one all adults with fever were treated with SP and microscopy was not performed Durlng phase 
two, all adults with fever had a blood smear and were treated with SP wthout the results of microscopy During 
phase three all adults with a history of fever had a blood smear and received treatment with SP only if malana 
parasites were found 
Study fzndlngs 
Use of SP and cost sau~ngs The proportion of prescriptions for SP fell during each phase of the study from 40% 
m phase one, to 21% in phase two to 7% in phase three The reduction of SP consumption during phase three 
would result in a sawngs at QECH outpatlent department of $17,430 per year Wlth an annual cost of $3 980 for 
microscopy (two technicians one phlebotomist supplies and stains), a change in policy that would require labora 
tory confirmation for the use of SP would produce a net savings of $14 470 per year for this facility 
The results of thls study are most applicable to hospitals where large numbers of patients are evaluated The 
cost of a technician to perform the microscopy would be the same even if fewer smears were done, although fewer 
smears would reduce the potential savlngs Furthermore, this study evaluated a strategy of lmlting drug treatment 
in adults, in whom the health consequences of malana are less severe than in children The treatment dose of SP for 
adults is larger than it is for children although the costs of microscopy are the same so applyng this strategy among 
chddren would result in smaller cost sawngs than among adults 
Impact on polrcy 
The plans for refurblshlng the outpatient department at QECH in 1994 include space for microscopists to 
interpret malaria smears A final decision on how to incorporate m~croscopy Into routine outpatient care had not 
been made as of September 1994 
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Ill D 2 b Assessment of malar~a vectors 
The questrons 
The 1990 1994 National Malana Control Plan included alternabve control methods as a program element and 
outlined strategies for blulding capacity in this area one of which was to better understand the characteristics of the 
malana vector populabon including its geographic and seasonal variations The evaluabon of malana vectors was 
seen as a first step toward examining the potential for malaria prevenhon through personal protection (e g insec 
ticide impregnated bed nets) and highly selectwe vector control As a consequence from October 1991 through 
September 1992 an assessment of malana vectors was carried out dunng four seasons m three geographically 
distlnct districts 
Study fmdrngs 
Malawian vector assessment teams were trained and MOH laborato y staff were taught laboratory skills to conduct 
field and laboratory evaluation of malaria vectors In three dstricts (Dowa District at 1 120 meters above sea level 
Mangochi District at the lake shore and 475 meters above sea level, and Nsanje District along the shores of the 
lower Shire river and 70 meters above sea level) vdlage-based collections of malana vectors were conducted at four 
times October November (dry season) January February (early ramy season) Apnl May (late rainy season) and 
August September (postrainy season) 1992 was a dry year and the rainfall dunng the rainy season was approxi 
mately one half of the average for these areas of the country Vector abundance in households, biting rates, and 
sporozoite rates (proporhon of vectors infected) were assessed 
Vector abundance and brtrng and sporozorte rates Anopheles gambrae s I and An funestus important vectors 
of malaria elsewhere in sub Saharan Africa were found at all sites in numbers that vaned by season and local~ty 
The entomologic inoculabon rate (EIR) (the number of infective bites/person/year) transmitted by both species 
combmed was estimated at 16 22 in Dowa 18 2 7  in Mangochi, and 1 1 6  in Nsanje Because the assessment 
occurred in an unusually dry year the actual average EIRs may be as much as 2 fold higher in each area Vector 
abundance and biting and sporozoite rates vaned by season with the highest seasonal EIRs seen in Dowa and 
Mangochi during the rainy and postrainy seasons However dunng the d y  season EIRs were lower and remained 
moderate along the lakeshore and lower Shire Valley (Mangochi Nsanje) but nearly undetectable on the plateau 
(Dowa) 
Impact on pollcy 
These studies trained a cadre a workers in malana vector assessment techniques and demonstrated that the 
major malana vectors in Malam are indoor bibng indoor resting species that bite pnmanly dunng sleep~ng hours 
The studies also showed that vector abundance and biting and sporozoite rates varied by season and locabon in the 
country (lakeshore and Shire nver valley versus plateau) Thus the use of insecticide Impregnated bed nets wdl likely 
reduce transmission of malaria because they are particularly suted to prevent indoor biting durlng sleeping hours 
The transmission reducbon that may be achieved by this control measure requres further evaluation because the 
expected 80% reducbon in transmission seen in other studies may still leave EIRs at greater than 5 infective bites 
per person per year and therefore may not actually alter infecbon and illness rates in the at risk populabons in 
Malawi 
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Ill D 2 c Econom~c ost of malar~a 
The questions 
The National Malaria Control Committee recognized that knowledge of the economic impact of malaria was needed 
to set realisbc research and program pnorlbes to improve malaria control program management Although the 
health burden of malana was known, no data exlsted on the economic burden of malaria in Malawi for households, 
the health care system, and the national economy In 1992 a senes of Interrelated inveshgabons was conducted to 
collect such data There were three parts 1) a nationwide household KAP survey which included questions on 
household expenditures for malana and bme lost to malana dlness 2) lnterwews of pabents mth malana at selected 
outpatient and inpatient facdities and 3) a retrospective hospital medical records review Durlng the KAP survey 
1 531 heads of households were questioned Over 1 000 malarla pabents were interwewed in the facilibes survey 
approximately 8,500 inpatient hospltal medical records were reviewed 
Study fmdlngs 
Household Income At the time of the survey, median income per household was $155 * Very low income 
households wrth an average annual income of $68 earned primardy (92%) through farm production represented 
52% of the households surveyed 
Drrect costs Only 10% of all households and 4% of very low income households reported any expenditures related 
to malana prevention However, all households reported some expenditure for malana treatment Malaria illness 
was common mth seasonally adjusted annuahzed estimates of 7 5 fever (malaria) episodes in children less than 10 
years of age and 6 1 episodes in adults Total annualized expenditure per household of four for malaria episodes 
was $19 83  or 4% of mean household annual income Among very low Income households expenditure was 
$19 1 3  or 28% of mean annual household income 
Malaria accounted for 34% of outpatlent vlslts and 15% 35% of all hospital admissions The annual cost to the 
health care system for the treatment of over 11 million outpatlent malana cases was estimated to be $1 3 million- 
$821,000 at MOH fachtles and the remainder at mission and other pnvate facditles Direct costs per malana case 
at MOH and PHAM hospitals were $49 and $22, respecbvely The total direct cost of inpabent malaria treatment 
borne by the MOH was $1 4 million, or 5 4% of the annual MOH budget 
Indrrect costs The value of t~me lost in caring for chddren with malaria was estimated to be $18-28 per household 
per year on the basis of the number of malaria episodes per child and the days of work lost per malaria episode in 
a chdd The value of bme lost due to adult malaria was estimated to be $4-$5 per adult per year givlng a total annual 
Indirect cost of productive time lost of $35-$44 million per year In Malawl (Table 7) In additlon results from 
prevlous studies estimating age-speclfic malana mortality rates in Malawl showed that the cost of premature mortal 
ity was estimated to be $63 million per year 
8Convers~on rate (1992) 3 Malaw kwacha = U S $1 00 
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Table 7 Dlrect and lnd~rect household costs of malar~a In ma law^, 1992 
Very low income Low to hlgh lncome 
All households households households 
$ (% of annual Income) $ (% of annual mcome) $ (% of annual ~ncome) 
Dlrect treatment 1983(4 1) 
Dlrect prevention 2 55 (0 5) 
lndrrect costs 12 75 (2 6) 
Total costs 35 13 (7 2) 
impact on polrcy 
This investigation prov~ded the first data on the direct and indirect costs assoc~ated with malana prevention 
and treatment In Malaw1 Malana represents a sign~ficant burden to the nahonal health sector and household 
economies th~s  finding provldes added support for Malaw s renewed efforts and investment m ~ t s  malana control 
program The information obtained from the economlc studies can be used to develop health educahon messages 
that wll help households combat malana most economically Such mformabon can also be useful to policy makers 
cons~derlng health financing strategies for Malaw1 s health care system Information on the economlc impact of 
malana is essent~al to donors and others Interested In the economic burden of disease and decisions about pnonty 
setting in resource allocatton 
Ill D 3 a Def~n~tron of parameters for evaluatmg drug eff~cacy 
The questzons 
With the increase in childhood morb~dity and mortal~ty due to anemla often directly caused by malana and concern 
that CQ resistance had lntens~fied the current efficacy of the fwt-line anhmalanal CQ needed to be assessed 
parasitologically, clin~cally and hematologically In addit~on parameters wth  which to judge the efficacy of any 
antimalarial needed to be defined In 1990 at Karonga Dlstnct Hosp~tal and m a subsequent follow up study In 
Mangochi, chddren less than 5 years of age with slgns, symptoms and laboratory documentat~on of malana were 
treated wlth either CQ 25 mg basekg over 3 days or SP of the WHO recommended standard dosing for age 
groups Parasitologlc cl~n~cal nd hematologic responses were measured 
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Study findings 
On the bas8 ofstudres wnducted insalEy rn Mafmt, II rs now accepted that the effl~aey of an anhmalar~al us& tatreat 
ch~ldren bss than 5 years of age {those at hrghesf rrsk for severe tlhess and death from mabrfa) can best be gudged by 
a mmbtnsttton of t&# ant~mdarcal's aQiL&y to allevrate symptoms of the d~sease, dear parasrfes and aftow an adequate 
pmsite free tntemf br hematohrc R C O W ~ ~ Y  [defined as  the re&rn ta pre+ffnms &el of hemogIobm concentraBonj 
(Bloiasld et al $993) Studms 8-1 Mafaw~ from f984 fhroumjh 199f demonstrated Watparastte reststance to CQ tntensrffed 
troth IR overitll ppevaience of resistant parmttes and In the propoffron of Rell resrstant paraslttas Chlamqurne's ssbse- 
auent faaIure fo clear penphral pams&mfa result& tfi  shortened duratr~n of dmrcal rrmprovement and madequate 
r&overy from the  ass&c&ed anernla Coilaborators m Maws agreed fhat ct was tlme to change io a drug that woutd 
clear parasr2emta when &@&me& resuReci a the followng a mean sus&rned dtmcat recovery less than 14 days and a 
me& hemoglobin concentratan rncrease m n g  anemtcd%ldsen {<8 gldh rnLalky) of tess than oa equal to 1 g l d ~  wtkm 
I4 21 days Experience n Malam suggested that these events oceur ln proporbon to the frequency of hrgh levet resrs 
tame, w&en RHI mfections account for more than 5%-70% of infecfrms these clinical and hematofog~c proMems wrll be 
observed h older mdfwidu;ds (those at tess nsk of mafarfa morbid@ and r n o W ~ ~ ,  the aeqmrement for paras& dear 
a m  m y  be  less mttml 
The recagnrtrosl ofclnimf and hematologrc effects of parasbe reststance was cr&d In makmg the decrsron &I c&angc?. 
tke nafconat polfcy tra Malawi These requfremem arebeag adopted elsewhere (e g K e v r  the World t-fealth Organr- 
Parasltolog~c and clrnrcal response to CQ Thls study found that more than 90% of children treated with CQ 
remalned parasltemic most resistance patterns were RII or RIII (Bloland et a1 1993) (Figure 19) Despite this high 
level of resistance, 78% of children treated with CQ became afebrde and had normal achwty levels within the ftrst 
48 to 72 hours after therapy In chddren who responded clinically, 37% had recrudescent signs of malaria within 
14 days after therapy and 58% had signs by 28 days after therapy Children with an RIII pattern of resistance failed 
sooner than chddren with an RII pattern In addition although approximately 80% of children treated with CQ 
achleved rapid resolution of fever and Improved clinically the median durahon of the cl~n~cal improvement after CQ 
therapy was under 2 weeks A follow-up study conducted in Mangochi in 1991 showed a very similar pattern of 
clinical failure after CQ therapy further supportmg the findmgs of the study (Figure 20) 
F~gure 19 In vlvo chloroqume res~stance proflies by s~te, Karonga (1990) and Mangoch~ (1991) 
S~te Karonga 
Number tested 123 
Res~stance level RI RII . Rlll 
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F~gure 20 Time from clinical improvement to clinrcal fallure for children less than 5 years of age 
treated with chloroqulne or sulfadoxine-pyrimethamme, ma law^, 1990-1991 
0 1  I I I I I I I I I I I I I I 
0 2 4 6 8 10 12 14 16 18 20 22 24 26 
Days after lnltial cllnrcal resolution 
Chlldren recelvlng chloroqulne wlth an Rill response and no resolut~on of cl~nlcal symptoms 
were excluded from thls analys~s 
These levels of resistance compare wlth findings from a 1985 study demonstratmg that although about 50% of 
ch~ldren remamed parasitemic 1 week after CQ therapy, over 90% became afebrile within 72 hours of CQ treat 
ment In later studles although there was a hlgher degree of parasltologic resistance the rate of inihai cl~nical 
response was similar (78% v 90%) but 58% eventually failed clinically (Pappa~oanou et al 1988) By 1990 1991 
an Increasing number of early parasitologic and clinical fallures was observed (Bloland et a1 1991a) 
Hematologlc response to CQ and SP Hematologlc improvement (increasing hemoglobin concentration or in 
creasing packed red blood cell volume) after treatment was also examlned in the studies conducted in 1990 and 
1991 The finding that hematologic response to CQ was Infenor to that after SP treatment was attnbuted to 
increasing CQ res~stance CQ resistance had become high enough to prevent chddren from achlevlng acceptable 
hematologic recovery (Bloland et a1 1991a) In cornpanson, chddren who were treated with SP a drug that rellably 
cleared parades remalned free of clinical symptoms and had significantly greater increases in hemoglobm concen- 
tration over the follow up penod (Figure 21) 
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F~gure 21 Mean hemoglobm change after therapy w~th  chloroqume or sulfadoxme-pyr~methamme, 
Malawf, 1991 
" 
7 14 21 28 
Follow up Day 
Chloroquine Sulfadome pyr~methamlne 
S~gn~f~cant d~fferences In mean hemoglobin p < 0 05 
Impact on polzcy 
Because treatment wlth CQ failed to produce elther lasting clinical improvement or adequate hematologic 
recovey CQ could no longer be considered adequate therapy of cl~n~cal P falctparum malana m Malawi s children 
(Box 8) In the treatment guidelines of 1992, regimens usmg SP replaced those ustng CQ for treat~ng vey young 
children and for chemoprophylaxis of pregnant women (see 111 D 2 b ) (Box 9) The gu~dellnes cited not only its 
greater efficacy, but rts increased likelihood of comphance (single dose required, tasteless) l~mited slde effects and 
low cost (comparable to CQ) The pohcy was implemented m March 1993 when sufflclent quantlt~es of SP were 
made avadable 
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Box 9 A crrttcal step Changmg first-hne therapy 
Because of the Importance of effectrve treatment and because of research results n 1990 and 1991 efforts from 
1991 through 1993 were rnvested n revrsrng the natronal pollcy to rncorporate the change from chloroqurne (CQ) b 
sulfadoxrne pyrrmetham~ne (SP) as the frrst Ime drug The steps Malawr took to rnlttate and implement thrs change 
are descr~bed below 
An October 1991 natronal meetlng in Mangochr revlewed recent study results and revrsed malarra treatment 
gurderrnes wh~ch were updated agarn m November 1992 and pr~nted The revised gu~dellnes of 1992 reflected 
three changes from the 1986 gurdellnes SF replaced CQ as the flrst lrne drug for treatment of matarra m young 
ch~ldren and for chemoprophykx~s for pregnant women It was also recommended that a patlent treated with 
cotrirnoxazore for a bacter~al rnfectlon (e g chest nfectlon) should not also be gtven an ant~malartal because 
cotrlmoxazole would also treat malarra The Natconal Drug Committee drscont~nued AQ as a recommended 
second lrne drug due to concerns about serrous s~de effects and ~ ts  Irm~ted benef~t w~th the hrgh level of CQ 
resistance rn Malawr 
fn early 7992, to furtherthe rmpbmentatron of the change rn drug poLcy a meetrng was held w~th representatrves 
of pnvate sector pharrnaceut~cal companies to encourage them b procure SP at the same time they dtowed the 
stock of GQ to declrne The offrcer In charge of the Central Medrcal Stores {the government agency responsrble 
for natronal drug procurement) had partmpated in the dacusstons that led to the replacement of CQ as the first 
l~ne drug By March 1993 the Central Medrcal Stores had purchased and drstnbuted sufficient amounts of SF for 
use tn the heakh deftvery system 
* In November 1992 the Malarra Control Program orgamed the lnformatlon Educatron Commun~catron materrals 
development workshop, whrch had multrsectoral representatron -personnel from the government, nongovern 
mental organrzatrons clrnrcrans and others rnvolved m the health delrvery system Treatment gurdellnes were 
frnalczed the 1985 treatment chart was remsed, radro messages were developed, and seven posters were 
destgned In September 1993, another workshop was held to develop materials that would help counter peoples 
perception that SP was not effecfrve Oral reports of an mfluenza outbreak m the country prov~ded a possible 
explanatran for the lack of confidence in SP The treatment chart was mod~fred to rnclude paracetamor m addit~on 
to SP The workshop also prepared materral for newspapers and radio (poems, storres, pgles and dramas) 
comtcsforschool use, and charts of the l~fe cycle of the mosqutto and malanaparaslte The postersdevebped at 
the 1992 rneetlng were mod~fred and SIX others were destgned 
Prror to the March $5 1993 offlclaf launchrng of the change from CQ to SP, reglonal meetlngs were held rn 
December 1992 and January 7993 to rnform d~str~ct health management teams composed of dlstr~ct health 
officers, matrons (nursmg supervrsors) dlstr~ct health rnspectors and pharmaceutrcal assrstants of the change 
These teams in turn btrefed other health workers rn therr dlsfrrcf Another briefing was held for malar~a control 
coordinators who were In charge of not~fyrng comrnunrty level health providers (tradrtronal blrth agendants, health 
surverltance asststants, village health workers, and shopkeepers) of the change By the end of 1993 all health 
workers had been mformed 
For the oifrcrat launchrng of the change to SP as the flrst lme drug the Mrnrster of Health rnvited other M$nrstry 
heads and the press to headquarters for hs address to the natlon The Secretary of Health had requested that 
hosprtats have enough SP to begrn drstnbut~on rn March and the M~nrstry of Health provrded flnanc~al assrstance 
to hosprtals foa purchase of the drug 
@ Affer the rntroductron of SP forms desfgned to track drug avalIab&ty, resrstance and adverse srde effects were 
drstrlbuted to dtstrlct health offlcers who were then responsrble for returning them to the Malar~a Control Programs 
offrce n Lllongwe 
Refresher tralnrng was conductedfor sentlnel surverflance personnef, mstruchng them rn the new poltcy the use 
of the new data collectron forms, and new health educat~on materrals 
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Ill D 3 b Effectwe regimen for preventmg malaria durmg pregnancy 
The questtons 
With the knowledge that an efficacious antimalarial delivered to women in their first and second pregnancies could 
prevent a significant amount of LBW (Steketee et a1 1993d) the National Malana Control Committee decided that 
prevention of malaria durlng pregnancy was a crltlcal Issue in child survival that warranted further investigahon To 
develop guidelines for maternal malaria control, the committee needed to identify an effective, practical antimalarial 
regimen A study conducted in Mangochi District dunng 1992 compared the efficacy in preventing placental 
malana cost and cost effectiveness of three regimens for women m theu first or second pregnancies 
1) CQ/CQ CQ treatment (25 mg basekg over 3 days) at init~al ANC visit (usually in the mddle of the second 
trimester), followed by CQ weekly (300 mg base), which premous studles had demonstrated to be slqhtly more 
effechve than the current recommended regimen of CQ weekly with no initla1 treatment dose (Steketee et al 
1993d) 
2) SP/CQ SP treatment at the inihal ANC mslt to clear parasitemla initially followed by weekly CQ prophylaxis 
to decrease the amount or occurrence of parasitemia 
3) SP/SP SP treatment at the initial ANC msit followed by a second treatment dose of SP at the beginning of 
third tnmester, which would clear parasitemia initially and agam at the hme of maximal fetal growth 
Study findrngs 
Effzcacy of candidate regrmens At their ANC visit, approx~mately 65% of women in their first or second preg 
nancy had perlpheral parasitemia (Schultz et a1 1994d) At least 24% of women receivlng CQ/CQ had perlpheral 
parasitemia throughout pregnancy, while fewer than 5% of the women receimng SP/SP were parasltemic at follow 
up assessments (Figure 22) At delivery, the group receivlng SP/SP had significantly lower rates of peripheral (3% 
versus 32%) and placental (9% versus 32%) parasitemia than women receimng CQ/CQ The difference in the 
efficacy of the regimens was even more sinking among women delivering during the high transmission season 
F~gure 22 Placental paras~temla mong pregnant women recelvlng ant~malar~al regimens, 
SPICQ 
0 SPISP 
Late ramy season* Dry season 
Refinlng t he  malarla control  polzcy a n d  program 1989-1 993 
Economlc cornpurlson of candldute regmens A declslon analysis model was used to estimate the cost effective 
ness of the candidate regimens when delivered to women in their first or second pregnancy (Schuitz et al 1 9 9 4 ~ )  
Given current levels of ANC attendance compliance with dispensed antimalar~als costs of anhmalarials and effi 
cacy of the antimalarial regimens the cost-effectiveness of the regimens (cost per case of LBW prevented) for SP/ 
SP, SP/CQ and CQ/CQ was estimated to be $9 66  $59 and $1 13 respectively The cost effectiveness of these 
regimens depended largely on the prlce of the antimalar~als the number of weeks of CQ prophylaxis drug efficacy 
and compliance 
Impact on polrcy 
In October 1992 results of thls study were presented at the Natlonal Malana Control Committee meehng 
On the basis of the need for maternal malarla control and the idenbfication of an efficacious and practical antlmalanal 
reglmen the SP/SP regimen was adopted as the recommended regimen for pregnant women As outl~ned m the 
study the regimen requred that women attending ANC be given one treatment dose of SP dunng the second 
trimester (usually the first ANC visit) followed by a second dose at the beginning of the third tnmester The regimen 
was recommended for women who were at least 1 6  weeks pregnant 
and excluded women with a history of sulfa allergy 
Ill D 4 Stud~es of malar~a treatment and prevent~on pract~ces 
Ill D 4 a Knowledge, alt~tudes, and pract~ces malar~a In ch~ldren and pregnant women 
The questrons 
The design of effectwe new health education messages resulbng from the change in the first line antlmalanal 
required an understanding of case management of febnle lllness in chddren in the community The deslgn and 
implementation of malana prevention strategies delivered through ANC also req~ured information regarding women s 
use of ANC and their percepbons of malarla dunng pregnancy Furthermore baseline data about malaria treatment 
and prevent~on were needed for subsequent monitonng and evaluation of policy and program changes This infor 
mation, along with information on general knowledge of malana illness malaria prevention and household expen 
ditures on malaria was collected in the spnng of 1992 dunng a nationwide malaria KAP survey (Steketee 1994) 
Study findings 
General malurla knowledge The KAP survey found that although malana is commonly reported and perceived to 
be a very important health problem both for chlldren and for pregnant women knowledge of malana and its effects 
was generally llmited and often erroneous (Ziba et al 1994) For example slightly more than half of the heads of 
household (55%) knew that malana was transmitted by mosquito blte 19% belleved cold weather to be responsible 
People s information about malana was obtained from a vanety of sources including health chnlcs, the radlo, and 
other people 
Management of febrlle rllness In chlldren Only 52% of caretakers took their febnle child to a clin~c for diagnosis 
and treatment These children were more llkely to recelve ant~malarials than children who were not taken to a clinic 
(Slutsker et a1 1994) Shll only 74% of clinic attenders reported being administered an antimalarial, compared 
with 42% of nonattenders Overall fewer than 10% of febrlle children received prompt (wthin 2 days of fever 
onset) treatment with a full dosage of the recommended antimalarial (Figure 23) 
Ref~n~ng the malar~a control pollcy and program 1989-1 993 
Flgure 23 Reported treatment of febrlle illness In children, natlonal survey, Malawl, 1992 
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Prompt tlmlng I NO 48% 
139 (83:) 
glven 1 8% 52 (161) 
75 (26 / )  
26% 
% of non 
attenders 
156(58/) 
I NO 58% 
Ant~malar~al 9 (91) 
glven 
84 (87 / )  
31% 
Proper dosage 
96 (91 1) 
12(13/) 
Beliefs and prachces about malana prevenhon dunng pregnancy The majonty of recently pregnant women, more 
than 90% of whom had attended ANC during their previous pregnancy, perceived malana as a health problem 
durlng pregnancy (Schultz et al 1994b) Though most women attended ANC, where they were given CQ prophy 
laxis to take weekly only 69% of women believed that antimalarials were effective in preventing malarla Further 
more, 36% of women thought that antimalarials were potenhally harmful to a pregnant woman or her unborn 
child 
HousehoId preuentron measures A little over half (52%) of the respondents reported uslng malaria prevention 
measures in their households (Ziba et a1 1994) (Table 8) Among users 47% reported use of purchased products 
while 64% used naturally available products Use of a purchased product for malaria preventlon was strongly 
associated with an lncreaslng educahon level of the head of household and an increasing household income level 
Table 8 Reported use of household prevention measures, natlonal survey, Malawi, 1992 
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Refrnrng the malarra control polrcy and program l989-l993 
Impact on polzcy 
Data gathered In the KAP survey provlded malana control pollcy makers w~th Important information to be 
used in designing and evaluating the success of health education messages aimed at increasing general awareness of 
malana, prompt and proper treatment of febrlle lllness In chddren and antlmalanal coverage among pregnant 
women These baselme data will be invaluable for monltonng and evaluating the effects of the changeover to SP for 
both treatment among young children and prevent~on among pregnant women 
Reftnmg the malarw control po[lcy and program 1989-1 993 
111 E Impact of stud~es on poky  a summary 
From 1990 through 1993, data collected and analyzed, principally from a series of field studies but 
also from national HIS sources, provided needed information for reusions of policy, planning, and 
national guidehnes for malaria control These were summarized in the previous section, important points 
are highlighted below 
The problem of malarm Several studies addressed three of the elements of the 1990-1994 
National Plan for Malaria Control (improved understanding of malaria, accurate diagnosis, and alterna- 
tive methods of control) The study of the overlapping diagnoses of malaria and pneumonia led to the 
recommendahon in the 1992 Treatment Guidelines that a child treated with cotrimoxazole, typically a 
drug prescribed for pneumonia, need not also be given an anbmalarial, as cotrimoxazole was effective 
treatment for malaria Additional studies of diagnoshc criteria for malavla (clinical and/or laboratory) 
have led to heightened awareness of the diagnostic problems posed by the disease and may lead to 
wider use of microscopy and the incorporahon of several clinical criteria beyond "history of fever ' into 
the presumptive diagnosis Studies of malaria vectors in Malawi have improved the understanding of the 
potential for personal protection measures (e g , insechcide-impregnated bed nets) as a transmission 
reduchon strategy Both the MOH and the private sector are interested in insecticide-impregnated bed 
net programs Finally, economic assessment studies demonstrated that malaria represents a major eco- 
nomlc burden to families and to the nation The current level of support from the MOH and the donor 
community reflects the recognition of this problem The methods used to collect these data in Malawi 
represent a standard that should be considered for similar future studies of malaria or other diseases in 
Malaw or elsewhere in the region 
Malarra mterventtons Two elements of the 1990-1994 National Plan (effectwe treatment and 
effective prevenhon in high-risk groups) were addressed Studies to evaluate the efficacy of CQ using 
parasitologic, clinical, and hematologic outcomes led to the replacement of CQ wth SP in the 1992 
Treatment Guidelines, the policy was implemented in 1993 when sufficient quantities of SP were avail- 
able WHO is currently considering adophng the methodology developed during these studies for stan- 
dard use when evaluating drug efficacy and selechng alternative antimalarial drugs for pvlmary therapy 
of uncomplicated illness On the basis of studies evaluating the efficacy and cost of CQ and SP regimens 
for the management or prevention of malaria during pregnancy, the national guidelines were modified 
to recommend SP in a two-dose intermittent treatment regimen for pregnant women Similarly, this 
methodology for examining prevention in pregnancy is being considered for use in other parts of Africa 
to refine treatment and prevention policies for pregnant women 
Malarra practrces Several elements of the 1990-1994 Nahonal Plan (improved understanding, 
effective management, and increased GOM and donor investment) were addressed by efforts to better 
understand malaria-related practices in Malawi Data from a KAP survey were crihcal for the design of 
health education messages for malaria prevenhon and control Also, the KAP survey provlded a baseline 
for current practices, wth the change of first-lme therapy to SP, further surveys can monitor and evalu- 
ate its effects Finally, linlung the KAP study to the economic study allowed for a household assessment 
of the impact of malaria in Malawi and provided evidence of the wdespread adverse health and eco- 
nomic impact that malaria has on Malawian families 
In addition to the above-menhoned impact of studies on policy and program development, there 
was tangible evldence of increased GOM support of malaria control in Malawi during the early 1990s 
The national level and district level staffing for malaria control was increased, and several staff were 
enrolled in postgraduate programs that emphasized public health, epidemiology, and malana control 
Refinrng the malarla control pollcy and program l989-lW3 
The research capacity has been generally strengthened with medical student involvement planned, con- 
tinued involvement of the drug efficacy team, and a newly tramed team capable of vector assessment 
studies 
During the years 1990 through 1993, important lessons were learned 
The systemabc approach toward policy, strategy, and guldellne development has continued to 
be essential for orderly development and growth of the National Malarla Control Program 
Development has been even more systematized under the 1990-1994 National Plan with its 10 
elements for action and the actimties conducted subsequently to address these elements 
The decision to change the first-lme drug in Malawi from CQ to SP was a major policy and 
program hurdle that could not have been considered wthout both data collected over time and 
analyzed in conjunction with key decision makers and the understandmg and willingness to 
confront the steps of national consensus, pharmaceutical group ~nvolvement, and the partic~pa- 
tion of national-, regional- and district-level personnel responsible for health educabon, tram- 
Ing, supervision, procurement, and dlstributlon 
The decisions to modify the prevention strategy for pregnant women succeeded by employing 
the same process as described In #2 
Programmahc Investment in insecticide-impregnated bed nets IS now possible because of the 
understanding gained from studies conducted in representatwe areas of the country 
Increased national and donor commitment requlres both data and constant attention from pro- 
gram staff, but it can be achieved, as the increased staff and modest supply and equipment 
resources that the Malawi program has obtamed attest 
Although it has been easy to recognize that training, supemslon, health education, and other 
elements of program support need strengthening, these remain difficult areas to affect and are 
often the last to receive attention and substantwe resources 
Malar~a Control Investment in Malam: 
A Natlonal Commitment and a Valuable 
Regional Experience 
Lessons learned in Malawi in the areas of operational research and policy and program develop- 
ment may help others plan more efficiently the needed steps toward malaria control Operational 
research conducted in Malawi has considerably expanded the technical database about malaria and 
effective control interventions rn endemic areas of sub-Saharan Africa (Box 10) Study findings have set 
the standard for work remaining to be done in the region 
The relevance of the Malawi experience extends beyond providing operational research standards- 
Malawi has also explored the requirements for policy and program development for malaria control 
The critical feature of Malawi s process has been its strong national commitment to developing an 
effective malaria control program With this commitment, it involved key decision makers and identified 
people capable of conductrng operational research who could identify the most Important techn~cal or 
programmatic obstacles, assess the issues through research and apply new-found informatron to 
rmproving the control program s effectiveness and efficiency A policy embracing regular monrtoring 
and evaluation of its program planning and implementation outcomes constitutes the model required for 
effective disease control programming Malawi made great strides in developing such a malaria control 
program 
Several elements of malaria control development in Malaw should be highlighted While these may 
not be models for other countries, they represent lessons for others to consider as they examine their 
own policy development process 
IV A Components of Malawl's success 
The study of technical issues served as an entry pomt for engagement and continued 
rnvolvement of key participants 
This document described the process of conducting operational research examining study results 
and making decisions based on locally collected information While this process has been central to 
policy, planning, and program development, it has also engaged junior MOH staff (clinicians, nurses 
public health staff, and other decision makers) and university staff and students By obtaining skills 
needed to gather data and to apply results to policy and program issues, staff and students have strength- 
ened their ability to contribute to the malaria control program 
The operational research activities engaged a variety of health care professionals, including physi- 
cians, who retain much of the decision-making power within the health sector Physicians involved in 
these activities were encouraged to seek the relevance of their research to the malaria control program 
Clinicians participated directly in evaluating determinants of antrmalarial drug efficacy, in drug efficacy 
monitoring, and in examinrng diagnostic crrteria for malaria and other diseases with overlapping symp- 
toms (acute respiratory infection) From this engagement, clinicians further recognized the role and 
determinants of patient participabon in effective malaria control Subsequently clinicians reviewed the 
Malaria control lnuestment rn Malawi 
Box 10 Standards set for operattonal research In Afr~ca 
Frrst Malawr provrdes the model to be followed for rn vrvo drug sensrtrvrty testrng and monrtorrng to 
develop the database for drug change The modrfred versron of the standardrzed WHO In vrvo testrng 
methodology that Malawr used proved to be fast accurate and feasrble Survey teams usrng thrs proce 
dure obtarned rnformat~on on parasrtologrc, clrnrcal, and hematologrc response on whrch to base pollcy 
One of the outcomes of thrs work was the understandrng that large, wrdespread frequent antrmalarral 
drug sensrtrvrty studres do not need to be conducted, rather rt IS more rmportant to obtarn repeated data 
In selected areas representatrve of the country s geography Applyrng this lesson could reduce markedly 
the trme needed to assess patterns of resrstance to antrmalarral drugs 
The MMRP and other studres evaluated the problem of rrralarra rnfectron In pregnancy They provrded the 
needed data to support the selectron of the target group (prrmrgrav~das and secundrgrav~das) and the 
need for preventron of rnfectron rather than only treatment of symptomatrc malarra In these areas of hrgh 
transmrssron typrcal of sub Saharan Afrrca Effectrve rnterventrons were desrgned one of whrch promlses 
to be especrally well-surted for rnclusron In a program of antenatal health care rntermrttent (twrce durrng 
pregnancy) treatment wrth a hrghly effrcacrous antlmalarral, SP The effect of the mothers malarra rnfec- 
tron on the chrld was fully explored, thrs work outlmed the quest~ons that need to be answered In other 
eprdemrologrc settlngs before effectrve programs are desrgned 
Malawr gathered baselrne data regardrng the current state of malarra knowledge attitudes, and practrces 
and the economrc rmpact of the drsease Not only were these studres rmportant In outlrnrng a methodol- 
ogy to follow but also rn emphasrzrng the rmportance of determrnrng baselrne rnformatron Even wrthout 
a formally constrtuted natronal malarra control program actrvrtres drrectly rmpactrng malarra control pro- 
grams are carrred out rn the communrty Mothers caretakers and communtty volunteers dragnose chrldren s 
fever and then provide treatment Those who would lrke to, and can afford to, purchase sprays nets and 
other Items rn order to prevent the ~nrtral rnfectron Malawr s experrence IS that understanding the back 
drop wrthrn whrch programs exrst IS essentral to formulatrng programs that are effrcacrous, effectrve and 
effrcrent 
The extensrve work conducted to defrne the problem of severe malarra and to formulate rnterventrons to 
manage Zhrs often fatal form of the drsease has allowed patlent evaluatron standards and treatment 
gurdelrnes to be developed Other countries can adapt these to therr own srtuatrons 
Frnally through contrnued rnternal and rnterna- 
tronal collaboratron rn Malawr, rnvestrgators have 
clarrfred the modes of rmpact of malarra rnfec 
tron and drsease (see flgure) Malarrologrsts have 
come to understand that the control of malarra 
mfectron and rllness must approach each of the 
aspects of the protean nature of the parasrte and 
rts effects preventrng rniectron from the mos- 
qudo, preventrng the progressron from rnfectron 
to drsease managrng acute uncomplrcated and 
severe ~llness, managrng or preventrng the more 
srlent forms of asymptomatrc' rnfectron (e g , 
anemra) and preventrng and managrng the 
pertnatal rmpact of rnfectron and ~ t s  assocrated 
rllness rn the pregnant woman or the conse 
quence of low blrth werght rn the newborn 
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Malarra control mvestment tn ma law^ 
KAP data, along with health education and public health specialists, to help focus malaria control pro- 
gramming efforts Clinicians also recognized the need to evaluate the economic impact of malarla and 
of disease control efforts in the context of economic limitations as an important step toward allocating 
resources and creating a program relevant to patient needs and means 
Technical issues that are highlighted in the document include 
Results of drug efficacy studies leading to changes in malaria treatment guldelines 
Results of studies in malaria in pregnancy leading to changes In prevention guldelines 
Knowledge, athtudes, and prachces (KAP) survey results leading to health education material 
design, 
Results for an economic study focusing donor and MOH attention to malaria issues, and 
Studies of severe and complicated malaria providing information for improved treatment 
guidelines 
Focused operat~onal research supported malana program development 
The contribution of operational research to program development has not been adequately under- 
stood or supported However, the experience in Malawi demonstrates the value of a partnership 
between program-relevant research and program development, in which focused scientific thinking 
supported and promoted program development 
In the evolution of the initial antimalarial drug efficacy studies and the subsequent studies to moni- 
tor drug efficacy, investigators in Malawi were faced with the question 'how will we know when the 
antimalarial drug is no longer effective? This question was answered by defining the parameters of 
effectiveness (1 e , to resolve malaria-associated illness for a sufficient length of time to permit full recov- 
ery of the child [including hematologic recovery]) and then by developing a scientific study to examine 
whether the drug accomplished these requirements Through this process, the information collected 
became directly relevant to the program s decision of when to change the first-hne antimalarial drug 
Another example of the partnership of research and program development is the MMRP This 
project was developed to answer a specific set of questions regarding whether or not a highly effective 
antimalarial drug used for prevention of malaria in pregnancy would lead to a reduction in the frequency 
of LBW in the population This population-based research program led to an answer to this question of 
regional importance, and at the same time results of the study led the MOH to seek an effechve, 
affordable, and safe regimen that could be promoted for malaria prevention in pregnancy In addition 
important observations on malaria in pregnant women and their infants were made The research 
fostered an ongoing collaboration between Malawian and U S based malaria experts that continued to 
support systematic approaches to policy and program development 
While operational research served many important purposes in Malawi, the operational research 
described in Malawi is not meant to be a recipe for all such studies to be conducted in each malaria- 
endemic country in sub-Saharan Africa In fact, it is hoped that information dissemination will play an 
increasing role so that relevant information from one country might be examined critically and adopted 
as appropriate to the local circumstances in another country in the same region For example, a large- 
scale longitudinal study of malaria prevention in pregnancy like the MMRP need not be repeated in each 
country Efforts are currently under way to develop simpler rapid assessment tools that can provide 
relevant information within a country These tools should facihtate the adoptlon of the broad principles 
of malaria prevenhon in pregnancy and help tailor the program to local needs 
Malarra control mvestment In Malawr 
The development of the malarra control rnfrastructure and management capac~ty IS best 
addressed by trarnmg 
Although much remams to be done within Malaw1 in infrastructure and management development 
the MOW has made a substantial effort to include staff in a variety of categories and levels provlde 
training and offer young staff leadership opportunities Malaw1 s malaria program has been bulk on the 
recognition that increasing management capaclty requlred both short- and long-term investment in 
tralning 
The ultlmate sustainab~lity of the malaria program or any other dlsease control program will be ~ t s  
ablllty to ent~ce people to participate to support them, to show progress and to reward them for work 
well done Malawi s program has contributed on these fronts largely through the recognition by a few 
that these issues were Important for the sustained nature of the effort Clinical officers were brought Into 
the decis~on mak~ng role laboratorians were involved on a co-equal bass and additional staff were 
trained in malaria control issues on their return from study abroad 
The control of malaria in Malawi is a dynamlc, ongolng process The investments to date In ~den 
tlfying the control challenges and effective control mtervent~ons and In nurturing a competent national 
staff have been essential initial steps Continued investments In these areas wdl be required as national 
attentlon moves to wlder applicat~on of the control strategies Increasing coverage and access of the 
Malawian population to malarla control sewlces Dlstlnct challenges remain that wdl requlre continued 
support and innovation to ensure that Malawl s malaria control program is effective 
IV B Challenges to be addressed 
Ensurrng adequate resources for malarla control As wth almost all d~sease control programs In 
developing countries the mala~ia control program In Malaw has been faced with a limlted MOH budget 
and contmued requirements for donor assistance While budget limitat~ons have not jeopard~zed the 
control program to date they have limited the plannlng capability and accompl~shments by the nat~onal 
program Recent data from the economic evaluat~on of the cost of malarla to the country and its people 
provide important documentation of need the MOH and donors must weigh this need agalnst other 
needs wthm the health sector 
Contmued attentlon to develop the malana control rnfrastructure The small staff (both tech- 
nical and admlnlstrative) and inadequate central resources (e g vehicles) for the Nat~onal Malaria 
Control Program also limit the capabil~ties of the program to prov~de regional and d~strict level gu~dance, 
supemslon, training, and other services 
Development of program management and admin~stratwe capacity As a the case through 
out the MOH, the staff of the malaria c6ntrol program have little or no tralning or experience 
in management and supervision Thls situation is unhkely to change except as improvements occur 
more w~dely within the MOH Addit~onal efforts to tram potentla1 leaders in these skills will need to be 
considered 
Ensur~ng sustainabl11t.y in malana control programming Like other dlsease control programs 
the National Malar~a Control Program faces the continual questlon of adequate staff and resources to 
carry out its misslon Recent efforts to train junior staff will undoubtedly foster the sustainab~llty of the 
program 
Malarza control znvestment zn Malawz 
IV C Malawi's experience and the Global Strategy for Malar~a Control 
Malawi s process of policy and program development was initially approached as a linear set of 
actions Deflning effective malarla control interventions was based on operational research designed to 
address a perceived lack of information The results led to policy definition, whlch was elaborated in 
malaria control plans and treatment guidelines The plans were then implemented and evaluated An 
impliclt assumption in the early stages of the malana control activities was that few malaria control 
actions were in place and that the national initiative would need to deflne policy and develop program 
infrastructure in total 
This implicit assumption was m retrospect inaccurate, and the reality of Malawi's experience is that 
the wide range of malaria control practices in place, including fever management by caretakers and 
practitioners, constituted a valuable basis for program development The national program examined 
interventions, e g , the effectiveness of CQ in treating children and pregnant women, and then changed 
policy accordingly New guidelines were set out for health staff to follow, and plans were implemented 
The recommended treatment was then reevaluated which led to a change in the first-line drug In effect, 
Malaw s paradigm for program development wds not linear but Iterative 
The process of policy and program development 1s not flxed not static The process must be 
constantly repeated, each step building on what has been learned and done before Treatment and 
prevention efforts always need to be evaluated in a systematic manner, and policy and program strate 
gies revised accordingly 
Malawi's experience accrued in the decade before the leadership of WHO and member countries 
adopted the Global Strategy for Malaria Control in Amsterdam in 1992 (WHO 1993) The Global 
Strategy defines several control strategies, placing priorlty on the development of effectwe malaria case 
management and prevention services for all populations at risk for malaria infection and illness, both 
acute uncomplicated and severe For effective case management, the Global Strategy recognizes that a 
national program must have data on the current efficacy of antimalarials Because of changing levels of 
antimalarial resistance, the strategy emphasizes that guidelines for case management cannot be rigid 
The Global Strategy s focus on prevention highlights the Importance of malaria prevention in pregnant 
women and the ' personal protection potentially provided by insectmde-impregnated bednets The 
Global Strategy also emphasizes that a malaria control program capable of providing effective treatment 
and preventive services will need a monitoring and evaluation mechanism, the results of which may 
prompt revision of malaria control plans and strategies Finally, the global strategy acknowledges that 
for many countries limitations of resources and infrastructure will mean that locally relevant and afford- 
able priorities will need to be established for malaria control 
The internal and mternabonal collaboration embraced by Malaw as it forged its National Malaria 
Control Program Influenced the development of the Global Strategy and showed Malawi s position in 
the context of country-level programs As noted in Box 9, the information generated from studies in 
Malawi that evaluated therapy efficacy and prevention effectiveness and set standards for assessing 
household practices and household and national expenditures has relevance both within the region and 
globally 
Malawi s experience with malaria control comes at a time when the Global Strategy must define its 
relevance to local conditions The translation of Global Strategy to natlonal and local programs is not 
dictated by formulas, but rather evolves from an assessment of malaria control priorities and of both 
financial and personnel resources available to the program The iterative process of monitoring and 
Malarra control ~nvestment In Malawr 
evaluation (including operational research) that supports an official planning process embracmg prompt 
and appropriate revisions in malarla control strategies is the core of program operations 
The mteractlon between the Global Strategy and national malaria control program must be 
dynamic Local translatton and adaptation of the guidance of the Global Strategy requires national 
initiative and perspective In this context, the experience in Malawi has particular value The national 
commitment to developing malaria control capacity will continue to evolve concurrently with the 
renewed global commitment to strengthen malaria control 
Many of the study results clted in the text have not been publrshed, the study reports restde 
zn the archives of Malawr's Mznlstry of Health The followrng lrst of references tncludes 
published artlcles crted In this text, reports to  the Minlstry of Health, and other artlcles 
descrzblng research conducted In Malawi durlng the years 1984-1993 
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